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Abstract
THE EFFECTS OF IMIPRAMINE ON LEARNED HELPLESSNESS 
Helga Friederike Remler, M.A.
The College of William and Mary in Virginia, August 1980 
Chairman: Professor Herbert Friedman
To study the "learned helplessness" model of human depression, 
the antidepressant drug imipramine was given to rats following help­
lessness training in the form of uncontrollable shock.
Behavioral indices of helplessness (escape latencies, escape 
failures, and shock avoidance) as well as physiological symptoms 
(changes in adrenal weight, incidence of gastrointestinal ulcers, 
changes in food and water consumption and in body weight) associated 
with uncontrollable shock were monitored. However, helplessness 
failed to develop which was attributed to procedural innovations 
employed in this study. Instead a tenuous preshock effect asso­
ciated with a high incidence of stomach ulcers was found in rats 
treated with saline but not in animals given imipramine. Other 
drug-induced changes of behavior produced in this study included 
faster improvement of escape latencies, especially at high shock 
intensities, and a decreased incidence of escape failures. 
Physiological symptoms induced by imipramine included acute consti­
pation, reduced food and water consumption, increased body weight, 
and ulceration of the intestines.
In the absence of helplessness, the behavioral changes media­
ted by imipramine were attributed to acute effects of the drug rather 
than to its antidepressant action. Most physiological symptoms were 
identified as anticholinergic side effects of the drug.
A number of hypotheses were evaluated in order to identify 
those neuro-physiological processes which may have mediated the drug's 
effects on behavior. These included central mechanisms subserving 
reactivity and arousal in response to intense stimulation, mechanisms 
subserving pain, motor activation, and the regulation of mood.
It was concluded that in lieu of a helplessness effect, the 
data did not allow for an evaluation of the model's applicability to 
human depression.
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THE EFFECTS OF IMIPRAMINE ON LEARNED 
HELPLESSNESS
Chapter 1 
Introduction
Learning theorists over the years have shown that men and ani­
mals are sensitive to many variations of contingencies between 
responses and their consequences. Both animals and men can perceive 
whether or not a result consistently follows a response, and they can 
actively learn that important events occur only when no specific 
responses precede them. Both types of contingencies are cases in 
which consequences are dependent on specific voluntary behavior.
The outcomes are, therefore, controllable, provided the organism is 
capable of learning the required responses. However, there are also 
circumstances in which the probability of an outcome is the same 
whether or not a given response occurs. Such cases are examples of 
response independence. When outcomes occur independently of specific 
voluntary behavior, they are uncontrollable. Seligman, Maier, and 
Solomon (1971) have defined uncontrollability as the condition in 
which the probability of reinforcement following an instrumental 
response is equal to the probability of reinforcement in the absence 
of that response. Uncontrollable events that are aversive or trau­
matic may produce an internal state which Seligman and Maier (1967) 
and Overmier and Seligman (1967) have coined "learned helplessness."
This line of research started as a result of the discovery 
that dogs which had been exposed to inescapable shock in a Pavlovian
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harness were incapable of escaping shock when tested after a 24-hour 
interval in a hurdle-jumping situation. They became helpless. After 
some initial attempts to respond adaptively, the dogs appeared unable 
to profit from successful responses when they did occur. They soon 
stopped responding altogether, and passively took all the shocks 
without defense. In order to determine whether helplessness resulted 
from the inability to control physical trauma or from experiencing 
physical trauma, Seligman and his colleagues used a tLriadic design 
which employs three groups: one group is given the opportunity to 
control shock by some specified instrumental response; a second 
group is yoked and receives exactly the same density and intensity 
of shocks as the instrumental animals without, however, being able 
to modify shock by any behavior; a third group receives no shock. 
Later, all groups are tested on a new task. A consistent result 
using this design has been the fact that, in comparison to the 
escape--and the control group, the yoked animals usually show dramati 
learning deficits, similar to the ones described, when subsequently 
exposed to a new task also involving shock. Since such deficits do 
not occur in the escape--or control groups, it is reasonable to con­
clude that helplessness does not result from the aversive stimula­
tion per se, but rather from the inability to terminate or otherwise 
control traumatic events.
These findings have been duplicated in fish (Padilla, Padilla 
Kellerer, & Giacalone, 1970), in pigeons, using response-independent 
food rather than aversive treatment (Engberg, Hansen, Walker, & 
Thomas, 1973; Welker, 1976), and in rats (Godkin, 1976; Hannum,
4Rosselini, Sc Seligman, 1976 ; Looney & Cohen, 1972; Maier, Albin,
6c Testa, 1973; Maier 6c Testa, 1975; Seligman 6c Beagley, 1975; 
Seligman, Rosselini, 6c Kozak, 1975). Finally, learned helplessness 
has also been induced in man (Gatchel 6c Proctor, 1976; Glass 6c 
Singer, 1972; Hiroto, 1974; Hiroto 6c Seligman, 1975; Price, Tryon,
6c Raps, 1978); Roth 6c Kubal, 1975; Teasdale, 1978..
Learning that trauma is uncontrollable has three effects:
1. Cognitive: Particularly germane to Seligman’s theory is 
the assumption that men and animals form expectations about their 
efficacy of responding. A history of uncontrollable trauma may 
distort this expectation and result in a negative cognitive set, 
producing a belief of one's inability to control the event even when 
such control is possible.
2. Motivational: Such a lowered expectation of success will 
also undermine the organism's motivation to initiate and maintain 
responding; it is this motivational deficit which underlies apathy 
and passivity in learned helplessness.
3. Affective or emotional: Fear and anxiety develop in an
organism confronted with traumatic events. Depending on the nature
of the situation, three kinds of learning can occur:
a. if the trauma is controllable, anxiety disappears;
b. if control is uncertain, anxiety remains;
c. if trauma is uncontrollable, anxiety is eventually
displ aced by the affective component of depression (Seligman, Klein,
6c Miller, 1976) .
The impetus for this particular study resulted, in fact, from
5the proposal (Seligman, 1974, 1975) that learned helplessness in 
animals may be a model of reactive depression in man. The common­
alities between the symptoms, physiology, etiology, and cure of 
learned helplessness and depression suggest that both conditions have 
their roots in the belief that valued outcomes are uncontrollable 
(Seligman, 1975). According to Seligman (1974), specific character­
istics of learned helplessness which are also shared with depression 
are as follows:
1. Helpless animals become passive in the face of later 
trauma; they do not initiate responses to control trauma. Similarly, 
depressed patients are characterized by diminished response initia­
tion; their behavioral repertoire is impoverished.
2. Helpless animals do not benefit from successful responses; 
depressed patients have negative expectations about the effectiveness 
of their own actions. They underestimate and devalue their perfor­
mances .
3 . In addition, evidence exists which suggests that both 
learned helplessness and depression dissipate in time.
4. Both conditions are associated with anorexia and weight
loss.
5. Both conditions are associated with depletion of central 
norepinephrine.
However, in spite of a number of empirical investigations 
(Klein, Fencil-Morse, 6c Seligman, 1 9 7 6 ;  Klein & Seligman, 1 9 7 6 ;  Miller 
& Seligman, 1 9 7 3 ,  1 9 7 5 ,  1 9 7 6 ;  Miller, Seligman, 6c Kurlander, 1 9 7 5 )  
which successfully tested certain predictions of the learned
6helplessness model of depression with human subjects, the possibility 
that a similarity exists between the two conditions is still vigor­
ously debated (Costello, 1978; Kilpatrick-Tabak 6 Roth, 1978;
O'Leary, Donovan, Kreuger, & Cysewski, 1978; Rippere, 1977; Rizley, 
1978; Sacco & Hokanson, 1978; Wortman & Dintzer, 1978). In response 
to these critics and to others (Blaney, 1977; Golin & Terrell, 1977; 
Wortman & Brehm, 1975) who have questioned the adequacy of theoreti­
cal constructs originating in animal helplessness for the under­
standing of depression in humans, the theory was recently reformu­
lated (Abramson, Seligman, 6c Teasdale, 1978). An attributional 
framework was incorporated, taking into account the complexity of 
human cognition and defense mechanisms.
The model has not only been criticized for its generaliza­
tion from animal data to human psychopathology, but also for the 
interpretation of animal behavior in terms of human emotions and 
cognition. Like Seligman and his associates, these critics 
(Anisman, 1 9 7 5 ;  Anisman 6c Sklar, 1 9 7 7 ,  1 9 7 9 ;  Weiss, Glazer,
Pohorecky, Brick, 6c Miller, 1975, 1976) have observed that uncon­
trollable shock produces disruptive effects on behavior as well as 
on neurochemical balances in the brain, and on physiological func­
tioning. For example, it was shown (Anisman, 1975; Anisman, 
deCatanzaro, 6c Remington, 1978; Glazer, Weiss, Pohorecky, 6c Miller, 
1975; Weiss & Glazer, 1975; Weiss, Glazer, Pohorecky, 1975,1976) 
that the stress associated with inescapable shock induces depletion 
of norepinephrine and an increase in acetylcholine. In addition, ani­
mals which are prevented from exercising control over shock develop
7higher plasma steroid levels, severe gastric lesions, greater loss 
of body weight, and more fearfulness in comparison to rats which can 
escape or avoid shock (Weiss, 1968, 1971a, 1971b, 1971c). Given 
the inability to test cognitive functioning in animals, these inves­
tigators have maintained that it is more parsimonious to attribute 
the behavioral deficits following uncontrollable shock to such non- 
associative processes as motor activity. Considering the fact that 
pharmacological treatments which deplete norepinephrine and/or 
dopamine mimic the disruptive effects of inescapable shock (Anisman, 
Grimmer, Irwin, Remington, & Sklar, 1979; Anisman, Remington, &
Sklar, 1979; Anisman & Sklar, 1977; Weiss, Glazer, & Pohorecky, 1976) 
a causal relation was hypothesized between amine depletion and a 
motor activation deficit (Weiss, Glazer, & Pohorecky, 1976) that 
hinders escape performance when the task necessitates vigorous or 
sustained responding (Anisman, deCatanzaro, & Remington, 1978).
Since the neurochemical changes induced by inescapable shock 
are relatively transient (Anisman, 1978; Stone, 1975), two alter­
native hypotheses, which emphasize learning, have been forwarded to 
account for the long-term effects of inescapable shock on subse­
quent escape performance. Glazer and Weiss (1976a), for example, 
showed that animals exposed to long duration shocks ( < 5.0 sec) 
exhibit biphasic behavior, with shock onset eliciting a high level 
of motor activity, and shock termination coinciding with relatively 
passive motor behavior. According to these investigators, the 
animals learn to lower their activity level in a subsequent escape 
task since their inactive motor behavior is reinforced by shock offset
8during inescapable shock treatment. A similar theory, also based on 
learning, was presented by Bracewell and Black (1974) and later by 
Black (1977) alone. Their argument, which is more general than that 
of Glazer and Weiss (1976a), also focuses on the behavior exhibited 
during inescapable shock treatment. It is their contention that at 
this time, animals may learn unauthorized responses which are incom­
patible with those necessary for successful escape. The extent of 
the interference would depend on the degree of incompatibility that 
exists between the responses acquired during inescapable shock and 
the responses required in the subsequent escape task.
In view of the controversy that still surrounds the claims 
of learned helplessness, this study attempted to test the model*s 
applicability to human depression by using the tricyclic anti­
depressant imipramine. It was hypothesized that if the drug would 
be capable of blocking the behavioral and possible physiological 
deficits that occur in learned helplessness and depression, these 
effects may be interpreted as supporting the adequacy of the animal 
model for human depression.
Imipramine1s efficacy in the treatment of depression, par­
ticularly of the endogenous ones, has been established (Klerman 6c 
Cole, 1965; Kuhn, 1958; Lehmann, 1966, 1968). In addition, the possi­
bility that treatment with imipramine may also be beneficial in cases 
of reactive depression has been indicated (Wittenborn, 1962). The 
complete mechanism of drug action responsible for its antidepressant 
effects has not been determined. However, the predominant view of the 
immediate biochemical sequence initiated by imipramine and other
9tricyclic antidepressants holds that this class of drugs enhances 
norepinephrine (NE) activity by blocking the reuptake of NE through 
neuronal membrane in peripheral and central NE neurons (Axelrod,
Whitby, & Hertting, 1961; Carlsson 6c Waldeck, 1965a, 1965b; Dengler, 
Spiegel, 6c Titus, 1961; Giachetti &  Shore, 1966; Glowinski 6c Axelrod, 
1965) , resulting in an increased availability of the physiologically 
active amine at postsynaptic receptor sites. In addition to its 
effect on NE, it is also well-established that imipramine blocks the 
uptake of serotonin (5-HT) into central serotonin neurons (Carlsson, 
Fuxe, 6c Ungerstedt, 1968; Fuxe 6c Ungerstedt, 1968, Lidbrink, Jonsson,
6c Fuxe, 1971). In fact, it has been shown (Carlsson, 1970; Carlsson, 
Corrodi, Fuxe, 6c Hokfelt, 1969a, 1969b; Sangdee 6c Franz, 1979) that 
imipramine is more potent in blocking the uptake of serotonin than of 
norepinephrine. Contrary to previous claims (Ross 6c Renyi, 1967), 
imipramine also interferes with the central reuptake mechanism of 
dopamine (DA) (Halaris, Belendiuk, 6c Freedman, 1975). Other effects 
of this drug’s action include the blocking of receptor sites for 
acetylcholine (Atkinson 6c Ladinsky, 1972; Rathbun 6c Slater, 1963) as 
well as of those for histamine (Domenjos 6c Theobald, 1959; McCulloch 
6c Story, 1972) .
In view of the variety of biochemical mechanisms that are 
affected by the tricyclic antidepressants, it was concluded (Rand 6c 
McCulloch, 1977) that a disturbance in any one neurochemical trans­
mitter system is unlikely to account for the therapeutic benefits of 
these drugs.
The drug effects on neurochemical mediators have not only proved
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to be important from a clinical perspective, but they were found to 
be of heuristic value too. Discovery of effective antidepressant 
agents has stimulated intensive investigations designed to eluci­
date their mechanisms of action in the hope of furthering under­
standing of the pathophysiology of affective disorders. One of 
the most influential biochemical theories to come out of the neuro- 
pharmacological studies of antidepressant action of tricyclics was 
the catecholamine hypothesis of affective disorders (Bunney & Davis, 
1965; Schildkraut, 1965; Schildkraut & Kety, 1967). This theory's 
hypothesis is that "some, if not all, depressions are associated 
with an absolute or relative deficiency of catecholamines, particu­
larly norepinephrine, at functionally important receptor sites in 
the brain" (Schildkraut, 1965). In addition, modifications of 
other bioamines have also been implicated in the pathogenesis of 
depression. For example, a serotonin hypothesis (Coppen, 1967; Lapin 
& Oxenkrug, 1969) has been advanced which holds that depressions may 
arise as a result of a deficit in brain serotonin. Changes in the 
interrelationships between catecholamines (NE and DA) and serotonin 
(Bueno & Himwich, 1967) or between these three transmitters and 
acetylcholine (Janowski, El-Yousef, Davis, & Sekerke, 1972; Prange, 
Wilson, Knox, McClane, Breese, Martin, Allton, & Lipton, 1972) may 
also contribute to the clinical picture of depression.
These theories are not in direct conflict with learned 
helplessness as long as they do not insist on a causal relationship 
that always originates in biochemical events. Seligman (1975) has 
stated explicitly that helplessness must have some neural and
11
biochemical basis and that the causal relation of physiology to cogni­
tion in helplessness goes in both directions: "Both cognition and phy­
siology influence helplessness. The two levels of change usually act 
in concert, but there are indications that either one alone can pro­
duce helplessness [ p. 74 ]."
Reports on the pharmacological profile of imipramine emphasize 
that there is no mood-changing or stimulatory effect except in 
depressed patients (Bickel, 1977; DiMascio, Meyer, & Stifler, 1968), 
suggesting a pronounced specificity toward the pathologic state.
In fact, administration of imipramine to normal subjects is known to 
produce effects perceived as unpleasant, Unsteady gait, dizziness, 
reduced ability to concentrate and think are some of the symptoms 
that may appear 50- to 100-minutes following ingestion of a single 
dose (Goodman & Gilman, 1975; Lehmann & Hopes, 1977). If such dif­
ferential drug effects also occur in rats, it could be anticipated 
that treatment with imipramine would improve the performances of 
helpless animals, but might produce performance deficits or fail to 
affect the performances of all other groups.
At the time this experiment was conducted (1977), only one 
other study (Weiss, Glazer, & Pohorecky, 1976) reported success with 
an antidepressant drug (parglyne) which belongs to the monoamine 
oxidase inhibitor family. However, only one dose was given prior 
to inescapable shock, and escape-avoidance testing was done as 
quickly as 30 minutes following the inescapable shock session. The 
authors interpreted the outcome in terms of their motor activation 
deficit theory and argued that parglyne had prevented the development
12
of a motor deficit, which is dependent on shock-induced depletion of 
norepinephrine in the brain, by interfering with the intraneuronal 
degradation of monoamines during the shock session. In contrast to 
the treatment sequence used by these investigators (Weiss et al., 
1976), this study adhered to the treatment paradigm applied to the 
treatment of depression in clinical practice, i.e., drug administra­
tion began only after the "depression-inducing” experience (uncontrol­
lable shock) had occurred. Also, again in closer resemblance to the 
clinical situation, drug effects were evaluated on long-term effects 
of uncontrollable shock which depend on learning (Black, 1977; 
Bracewell 6c Black, 1974; Glazer & Weiss, 1976a) rather than on the 
transient consequences of neurochemical imbalances induced by the 
shock treatment (Anisman, 1978; Stone, 1975).
In addition to testing the efficacy of treatment with 
imipramine on the alleviation of learned helplessness, this study also 
evaluated the effect of prior experience with control over trauma 
on the susceptibility to learned helplessness. Some success with the 
reduction of shock-induced behavior deficits in rats through prior 
exposure to controllable shock has been reported (Looney 6c Cohen,
1972; Seligman, Rosselini, 6c Kozak, 1975 [ Experiment 2 ]; Weiss 6c 
Glazer, 1978 [ Experiment 2 ] Weiss, Krieckhaus, 6c Conte, 1968 
[ Experiment 3 ]). However, in all four cases, the pretraining pro­
cedures and later testing for behavioral deficits were conducted in 
the same experimental settings and, with the exception of the study 
by Seligman, Rosselini, and Kozak (1975), involved the same instru­
mental response. But, such procedures, by allowing positive transfer
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of place--and/or response learning to contribute to better perfor­
mances on the subsequent task, subtract from any claim which 
attributes the improved performances to effects of cognitive pro­
cesses. Therefore, in an effort to minimize the possibility that 
animal behavior is affected by variables not tested by the model, 
this study evaluated the effects of proactive experience with 
escapable shock on the subsequent development of learned helpless­
ness by using the following controls:
1. Different environments and instrumental responses for 
pretraining, helplessness training, and subsequent escape/avoidance 
testing;
2. Longer intervals between pretraining, helplessness train­
ing, and escape/avoidance testing in order to differentiate any long­
term effects of proactive treatment from transient neurochemical 
changes.
In summary, the primary purpose of this study was to test 
the adequacy of learned helplessness for human depression through 
the use of an antidepressant drug which is known to reduce symptoms 
not only of endogenous but of reactive depression as well. It was hypo­
thesized that if imipramine selectively improved the performances 
of helpless animals, then some parallels between the biochemical states 
subserving learned helplessness and depression might be drawn. A 
secondary purpose of this study was to test the efficacy of prior 
control over shock on the subsequent susceptibility to helplessness. 
Given the possibility that learned helplessness may be analogous to 
depression, positive results of such an experience would have
14
implications for prophylactic treatments of depression.
Chapter 2 
Method 
Subjects
A total of 70 naive male Sprague-Dawley (Holtzman) rats 
weighing from 350 to 471 g served as subjects. The animals were 
3-months old on arrival at the laboratory. They were housed indi­
vidually for a period of approximately 3-1/2-months until experi­
mentation was begun. During this period, they were handled twice 
a week. The rats were maintained on a 12-hour light/dark cycle and 
at a room temperature of 21°C. Subjects were given Purina Lab Chow 
and tap water ad-lib for 1-month following their arrival.
Subsequently, the animals were placed on an 85% fixed body weight 
deprivation schedule (Weinstock, 1972) with ad-lib water maintained.
Oxytetracyclene HCl (obtained from Sussex Drug Products Co.) 
was administered to all subjects in a 1-tablespoon/2-quart concen­
tration in their drinking water during the first week of their 
stay. This treatment was initiated in response to respiratory symp­
toms shown by some of the animals, indicating the possibility of the 
presence of infection. All symptoms subsequently disappeared.
Apparatus
Training with controllable shock during Phase I of the experi­
ment was conducted in a BRS/LVE toggle floor shuttle cage (model No. 
146-04), equipped with a scrambled shock harness (model No. 146-94), 
and a shock scrambler (model No. 113-33). Subsequent escape training
15
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In Phase II was done in three identical Lucite restraining tubes 
(21.0 x 7.0 x 7.0 cm) which were mounted on a wooden base (72.4 x 
23.5 x 1.9 cm) and were separated by wooden partitions (72.4 x 
14.0 x 1.9 cm). The front of each tube was shaped like a cone 
with a small hole at its center measuring 1.9 cm at its diameter.
A microswitch was placed outside each tube at a distance of 1.3 cm 
from the hole. The animal given the opportunity to escape from 
shock was required to push this switch forward with its nose in 
order to interrupt the circuit and terminate shock. A door which 
could be placed at various points of the restraining tube (depending 
on the length of the animals) prevented the rats from backing out.
Each door was provided with a hole through which the animal's tail 
could be guided for application of a tail electrode. All three elec­
trodes were constructed according to the specifications by Weiss 
(1967). They were wired in series in order to equalize number and 
duration of shocks as well as physical magnitude of shock intensity 
for all three animals being tested at one time.
Shock was delivered by a BRS/LVE constant-current shock 
generator (model No. 315-04), programmed to send out pulses of 1.5 
sec duration at an interval of 0.1 sec.
Escape/avoidance testing during Phase III was conducted in 
a wheel-turn chamber which was mounted on a wooden base (see Figure 
1). Inspection of the figure shows that the wheel which was made 
out of wood was covered with smooth sandpaper. A mirror was installed 
on its side which, during rotation, interrupted the rays of a light 
source directed at a photo cell which controlled the shock circuit.
17
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Figure 1. Phase III: Wheel turning cage.
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The sensitivity of the shock termination mechanism was controllable 
by adjusting the intensity of the light source. The figure also 
shows that the surface of the wheel was quite small so that place­
ment of the paws for wheel-turning required considerable skill and 
precision, especially during the stress of shock. Shock was deliv­
ered to the tail which extended to the outside of the chamber through 
a hole in the hinged door of the apparatus. Shock electrodes were 
the same as those used in Phase II. A small buzzer which was covered 
by a metal housing and was mounted on a wooden base was used during 
this phase.
Equipment for Physiological Examination
A dissecting microscope and a high-powered microscope with 
a camera were used for inspecting, measuring, and photographing 
stomach--and intestinal lesions. Photographs were taken with Kodak 
Panatomic-X film.
Procedure
All animals were randomly assigned to four groups which, in 
turn, were divided into a drug--and saline condition, making a total 
of eight groups. The experimental design is illustrated in Table 1.
Group ES-IS (Escapable shock--inescapable shock). This group 
was trained with escapable shock in the shuttle box (Phase 1) 48- 
hours prior to exposure, to inescapable shock in the restraining tube 
(Phase II).
Group NS-IS (No shock--inescapable shock). Animals of this 
group did not receive training with escapable shock in Phase I.
They were given inescapable shock treatment in the restraining tube
19
Table 1 
Experimental Design
Group Treatment Interval Treatment Interval Treatment
ES-IS Phase I 48 hours Phase II
FR-1 shuttle 
box;
escapable/ 
unavoidable 
shock
NS-IS --
NS-ES -■
Res training 
tube,;
inescapable/ injections)
48 hours Phase III
(5 Imipramine/ Wheel-turn 
saline chamber;
unavoidable 
shock 
Phase II 48 hours
escapable/ 
avoidable 
shock 
Phase III
Restraining 
tube; saline
inescapable/ injections) 
unavoidable 
shock 
Phase II
(5 Imipramine/ Wheel-turn 
chamber; 
escapable/ 
avoidable 
shock 
Phase III
Res training 
tube;
escapable/
unavoidable
shock
48 hours
(5 Imipramine/ Wheel-turn
saline 
inj ections)
chamber; 
escapable/ 
avoidable 
shock
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Table 1--Continued
Group Treatment Interval Treatment In t e rva 1 Treatment
NS-NS -- 48 hours Phase III
(5 Imipramine/ Wheel-turn
saline chamber;
injections) escapabl e'/
avoidable
shock
21
(Phase II).
Group NS-ES (No shock--escapable shock). Animals did not 
receive shock training in Phase I. They were given escapable shock 
in Phase II.
Group NS-NS (No shock--no shock). These animals did not 
receive shock treatment in either Phase I or Phase II. They were 
allowed to remain in their cages until escape/avoidance testing was 
initiated in the wheel-turn chamber (Phase III).
For all three phases subsequently described, shock was pro­
grammed and delivered automatically on a variable interval (VI) 60-sec 
schedule with a mean of 60 sec between shocks and a total range of 
10- to 110-sec.
Phase I: ES-IS animals were deprived of food but not of 
water for 24-hours preceding the shock session. They were given 45 
nonsignalled trials in the shuttle cage. Shock intensity was set at
1.0 mA, and maximum shock duration at 30.0 sec. During all trials, 
the rat had to cross the shuttle box once (FR-1) in order to escape 
from shock. Shock was terminated automatically after an animal had 
made the crossing to the safe chamber. Time to respond from the 
onset of shock to successful shock termination was defined as 
latency. If the animal failed to respond within 30.0 sec, shock 
was automatically terminated, a latency of 30.0 sec was recorded for 
that trial, and the intertrial interval was initiated.
In order to minimize transfer to Phases II and III via eniron- 
mental stimuli, training in the shuttle cage was conducted in a sepa­
rate room that was not used in any of the subsequent phases.
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Phase II: Treatment in the restraining tubes was initiated 
48 hours after completion of Phase I. For the first 24-hour inter­
val, animals were fed ad-lib; during the second 24-hour interval, 
they were deprived of food but not of water. A triad was formed of 
one rat each from groups ES-IS, NS-IS, and NS-ES. The tails were 
cleaned with alcohol, electrode paste was applied, and a plexiglass 
ring was slipped on the tails, followed by the electrode and a short 
piece of plastic tubing to keep the electrode in place.
Only the switch of the escaping animal (NS-ES) could produce 
shock termination. The remaining two animals were yoked. All three 
switches, however, were connected to counters which recorded the 
number of nose-poking responses made by each rat. This response 
required that the rat projected its nose through the central hole at 
the front of the tube and pushed the switch forward. A cumulative 
nose-poke response record was kept for all but the initial two triads. 
Shock treatment consisted of 12 training trials during which shock 
intensity was increased gradually from 0.4 mA to 0.8 mA and 1.0 mA 
(4 trials each), and 73 trials with shock intensity set at 1.0 mA.
All 85 trials were conducted in one continuous session. Shocks
were not signalled. Maximum duration was 5.0 sec. Response latencies
were recorded for the escaping rat (NS-ES).
Immediately following this treatment, animals were assigned 
to either the saline--or imipramine condition and given their first 
of 5 injections. Also, monitoring of body weight as well as of food-- 
and water consumption was initiated at this time.
Phase III: Escape/avoidance testing on the wheel was conducted
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in the same room that had been used in Phase II. The trials were 
initiated approximately 40 hours after completion of Phase II. At 
this time, the control animals (NS-NS), which up to this point had 
been taken out of their cages only for injections and weighings, 
were added to each group. Escape/avoidance testing was done indi­
vidually in the wheel chamber with shock delivered to the tail as 
described for Phase II. However, shock in this treatment phase was 
signalled. A buzzer was sounded for 5.0 sec prior to shock onset and 
was paired with shock. Shock was set at a maximum duration of 30.0 
sec. It could be terminated by a partial wheel turn, the extent 
of which was dependent on the distance of the mirror from the light 
source at the beginning of each trial. Thus, the extent of the wheel 
rotation required for shock termination differed from trial to trial 
and was left up to chance during the last 30 trials. Response 
latencies were measured from the onset of shock to shock termination. 
If no successful response was made, a 30.0 sec latency was recorded.
If an animal turned the mirror past the light source, thus inter­
rupting the light rays, during the 5.0 sec CS-US interval, the 
sound of the buzzer stopped, and shock was avoided. A latency of 0 
was recorded for such trials. In addition, the number of wheel turns 
(each 360° rotation equalled one response) were monitored by a counter 
as an index of motor activity.
There were 14 training trials of gradually increasing shock 
intensity (4 each at 0.4 mA, 0.6 mA, 0.8 mA, and 2 trials at 1.0 mA) 
given before the 30-trial session of 1.0 mA shock intensity was 
initiated. In order to differentiate the two sessions procedurally,
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the training trials were designated as Testing I and the remaining 
30 trials comprised Testing II. During Testing I, rats were given 
assistance in wheel turning. Prior to the beginning of each new 
trial, the mirror was set manually at successively greater distances 
from the light source, requiring a gradual increase in effort of 
wheel turning. During Testing II, which was continuous with Testing 
I, the rats had to terminate shock completely unaided. This procedure 
was instituted in order to provide gradual adjustment to shock and to 
eliminate failures that might be attributed to factors other than 
prior behavior treatment.
After completion of escape/avoidance testing, each animal was 
returned to its home cage. Approximately 3- to 4-hours later, each rat 
was sacrificed by decapitation in order to protect physiological func­
tioning from the effects of additional drugs or stress.
Physiological examination. The animals were checked for 
stomach and intestinal lesions. Intestinal ulcers had not been part 
of the original design. However, their presence was discovered acci­
dentally halfway through the experiment. Consequently, only 34 animals 
were examined. In addition, adrenal glands of all animals were freed 
of their surrounding fatty tissue, cleaned with saline, and weighed. 
Stomachs were opened along the greater curvature, rinsed with saline, 
and pinned down on wax plates for inspection. Intestines also were 
opened and pinned on wax. All gastrointestinal tissues were subse­
quently examined for lesions under a dissecting microscope. Lesions 
were measured under a highpowered microscope and photographed. A 
lesion was characterized by a visible break in the mucosa which
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was surrounded by an area of local edema and often accompanied by 
intense vasodilation (cfm. Figures 8, 9, 10).
Drug treatment. Animals in the drug condition received 5 
injections of 15 mg/kg imipramine (Geigy Pharmaceuticals) i.p.
This dosage was selected on the basis of work by Kornetsky (1965), 
Morpurgo (1965), Bindra (1963), and Niemegeers (1962). The first 
injection was given immediately following completion of Phase II. 
Subsequent injections were administered every 10 hours. The last 
drug treatment was given 15 minutes prior to escape/avoidance 
testing (Phase III). Saline treatment was administered in the 
same concentration and on the same schedule.
Hypotheses
The following hypotheses regarding performances in Phase III 
were tested.
Hypothesis 1
In accordance with Seligman's model, it was predicted that 
NS-ES saline rats should perform better than NS-ES saline rats. 
However, since in Phase II, NS-IS animals were able to make the same 
though nonreinforced responses as NS-ES rats, it would be difficult 
to attribute any changes in their behavior in Phase III to the com­
patibility of previously learned motor responses in Phase II. 
Hypothesis 2
On the other hand, NS-IS animals treated with imipramine 
should perform equally well as NS-ES saline rats.
Hypothesis 3
ES-IS animals treated with saline were expected to perform
26
better than NS-IS saline rats. If ES-IS animals were, however, 
affected by a competition of motor responses, their performances 
should be similar to those of NS-IS saline rats.
Hypothesis 4
The performances of NS-IS animals treated with imipramine 
were predicted to be superior to those of NS-IS saline rats. 
Hypothesis 5
It was expected that the performance of NS-ES and NS-NS 
rats treated with imipramine would be equal to or inferior to per­
formances of NS-NS saline rats.
Hypothesis 6
It was predicted that proactive training of ES-IS saline 
rats in Phase I would produce performances that would be equal to 
those of NS-IS animals treated with imipramine.
Chapter 3 
Results 
Statistical Treatment 
The main analyses of the data were made by analysis of vari­
ance, type S.P.F. 42.4 and 42.6 (Kirk, 1968), a split plot design 
for 4 groups, 2 drug conditions, and 4 or 6 repeated measures. Type 
S.P.F. 22.4 and 22.6 (Kirk) were used for the analyses of preshock 
effects. Two-factor analysis of variance (Kirk) was performed on 
the majority of the remaining data. Single-factor analyses 
(randomized block design, Kirk) were done on blocks of trials data 
produced in Phase I and Phase II. Stomach and intestinal lesions 
were analyzed by chi square (Friedman, 1972). Analyses of perform­
ances at specific pairs of blocks of trials were done by J:-test for 
related samples (Friedman). Analyses of drug conditions at specific 
blocks of trials were performed by _t~test for independent samples 
(Friedman). A posteriori comparisons of means were made using 
Tukey’s HSD procedure (Kirk). The rejection region for all statisti­
cal tests was set at £ < .05. Magnitude of experimental effect (t )
was listed for all significant results (Friedman).
Phase I
(Training with escapable shock in the shuttle box.) All ES-IS 
rats learned to escape from shock in the shuttle cage, F (8,152) = 
6.44; p < .01, eta = .50. The mean shock duration per trial was 
1.9 sec. Figure 2 shows the mean latencies which are declining across
27
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Figure 2. Phase I: Mean escape latencies (sec) of ES-IS rats (n = 20) 
escaping from foot shock in one-way shuttle cage.
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blocks of trials.
Phase II
(Training with escapable shock in the restraint.) There were 
6 NS-ES rats (3 in each drug condition) that did not learn to escape 
from shock in the restraint. Their mean shock duration per trial out 
of 5.0 sec maximum was 4.8 sec. Table 2 illustrates that their long 
latencies were apparent right from the first few trials and remained 
consistently long until the end of the session. In contrast, mean 
shock duration for all remaining rats was 2.2 sec. Figure 3 which 
does not include the data of these 6 nonlearners, shows that response 
latencies decreased over blocks of trials; _F (10,130) = 22.44; £ <
.001; eta = ..80,, confirming that animals learned to escape from 
shock.
Subsequent data analyses, unless specified, do not include 
contributions from these 6 NS-ES rats. Table 3 summarizes the mean 
number of nose pokes emitted by all rats during the treatment ses­
sion in the restraining tubes. In order to minimize the distortion 
effect of occasional responding at very high rates, square root 
transformations were performed on the data. Analysis of variance 
confirmed that the group differences were reliable, F (2,51) =
21.26; £ < .001; eta = .70. Pairwise comparisons showed that all
three groups had scores which differed significantly from each other. 
NS-ES rats emitted the highest number of nose pokes (transformed mean =
13.26; £ < .01), and NS-IS rats (mean = 7.34) made more responses than
ES-IS rats (mean = 3.54; £ < .05). A cumulative record of nose poke
means in Figure 4 shows the response distribution over time (blocks of
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Figure 3. Phase IX: Mean escape latencies (sec) of NS-ES rats (n - 14) 
escaping from tail shock in restraining tubes.
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Table 3
Phase II: Mean Number of Nose Poke Responses 
Emitted during Shock Treatment in the 
Restraining Tubes
Group treatment Norm Mean
nose
pokes
NS-ES (n = 14) 13.26
NS-IS (n = 20) 7.34
ES-IS (n = 20) 3.54
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Figure 4. Phase II: Cumulative nose poke means per block of trial.
Mean number of nose pokes per trial are indicated on the 
slopes for each group of rats.
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trials). Since this type of record keeping was initiated after 6 
animals (two triplets) had already been tested, the total number of 
nose pokes is, therefore, incomplete for all three groups. In order 
to compare rates between blocks, all slopes were labelled with mean 
number of nose pokes per trial. As evident in the figure, NS-ES rats 
responded at uniformly higher rates, ranging from 2.4 to 2.6, than 
either NS-IS or ES-IS animals throughout the entire session. It is 
interesting to note, however, that NS-IS rats also responded at a 
relatively stable rate, ranging from .95 at the beginning of the 
session to 1.08 and 1.05 nose pokes per trial during the last two 
blocks. Unlike the performance by the ES-IS group, their response 
rates did not level off significantly over time. In contrast to the 
other two groups, ES-IS animals produced their highest response rate 
(.35) during the first block of trials and the lowest rate (.18) 
during the last block.
Phase III
(Testing with avoidable/escapable shock in the wheel-turning 
chamber.) The mean latencies of all eight groups reflecting time to 
escape from or avoid signalled shock by wheel-turning is shown in 
Figure 5 as well as in Tables 4 and 5. In order to reduce the dis­
tortion effect of occasionally long latencies within each group, 
square root transformations were performed on all scores. As indicated 
in Figure 5, the 10 blocks of trials were divided into two separate 
phases of testing. Testing I describes the first four blocks of 
trials during which all animals were given assistance in wheel-turning. 
Testing II describes the subsequent six blocks during which the rats
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Phase III: Mean escape/avoidance latencies (sec) of all 
groups treated either with saline or imipramine immediately 
after completion of Phase II. The data were subjected to 
square root transformation.
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Table 4
Phase III: Mean Escape/Avoidance Latencies 
in Testing I
Drug
treat­
ment
Group
treat­
ment
Blocks of Trials
Mean
1 2 3 4
Saline NS-ES (n = 10) 4.22 3.61 3.69 3.86 3.85
NS-ES (n = 7) 3.98 3.10 3.11 3.64 3.46
NS-IS (n = 10) 3.76 3.36 3.10 3.13 3.34
ES-IS (n = 10) 4.05 3.26 3.34 3.36 3.50
NS-NS (n = 8) 3.07 2.98 2.80 2.26 2.78
Mean (n = 35) 3. 72 3.18 3.09 3.10 3.37
Imipramine NS-ES (n = 10) 3.56 2.75 2.29 2.03 2.66
NS-ES (n = 7) 3.43 3.04 2.43 2.35 2.81
NS-IS (n = 10) 3.94 3.61 2.99 2.27 3.20
ES-IS (n = 10) 3.51 2.82 2.68 2.54 2.89
NS-NS (n = 8) 3.90 3.09 2.58 2.29 2.97
Mean (n = 35) 3.70 3.14 2.67 2.36 2.93
Grand Mean (n = 70) 3.71 3.16 2.88 2.73 3.12
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had to turn off shock without help. Both testing phases were con­
tinuous in time. The four blocks of Testing I coincided with differ­
ent magnitudes of shock intensity, starting with 0.4 mA at block I.
At block IV, the maximum shock intensity of 1.0 mA was reached, and 
shock was maintained at this level for all trials of Testing II.
Testing I. Analysis of variance showed that there were negli­
gible group differences ,_F ( 1,62) - 1.08, and group x drug interaction,
F (3,62) = 1.44. There was a small, nonsignificant drug effect, F 
(1,62) = 3.22; £ < .10. When escape/avoidance latencies were examined
that included the data of the 6 NS-ES rats which had not learned to 
escape from shock in Phase II, it was shown that imipramine animals 
responded faster than saline rats, F (1,68) = 7.08; £ <  .01; eta =
.30. Also, there was a reliable group x drug interaction, F (3,68) = 
3.33; £ < .05; eta = .35, showing that among saline animals, NS-ES 
rats had the longest mean latency (3.85 sec) and that NS-NS rats had 
the shortest mean latency (2.78 sec). Comparisons of means across 
drug conditions further revealed that NS-ES imipramine animals had the 
shortest mean latency (2.66 sec) of all groups. Group differences were 
not significant, F (3,68) = 1.31. Adding the data of the nonlearners 
had the effect of substantially increasing the mean latencies of the 
NS-ES saline rats and decreasing the mean latencies of the NS-ES 
imipramine rats for Testing I of Phase III, thereby polarizing the 
saline and imipramine groups sufficiently to produce the drug-related 
statistical effects. Table 6 shows the escape/avoidance latencies of 
the three saline and three imipramine animals of the NS-ES group at 
all blocks of trials of Testing I. It also shows, for comparison,
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Table 6
Phase III: Mean Escape/Avoidance Latencies 
of 6 NS-ES Rats in Testing I 
(mean seconds)
Block 1 Block 2 Block 3 Block 4
Imipra- Saline 
mine
Imipra­
mine
Saline Imipra­
mine
Saline Imi­
pramine
Saline
3.81 4.98 1.30 5.48 1.34 5.26 1.30 2.82
4.12 4.46 1.59 3.40 1.94 4.76 1.69 5.09
3.74 4.97 3.38 5.48 2.57 5.09 0.82 5.26
Mean (n = 3)
3.89 4.80 2.09 4.79 1.95 5.04 1.27 4.39
Mean (n = 7)a
3.43 3.98 3.04 3.10 2.43 3.11 2.35 3.64
Successful NS-ES rats
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the group means of the remaining 7 NS-ES rats in each drug condition. 
The data illustrate that at each block, the means of the 3 NS-ES 
animals treated with imipramine (3.89, 2.09, 1.95, 1.27) are not 
only shorter than those of the 3 saline rats (4.80, 4.79, 5.04, 4.39) 
but--with the exception of performances at block 7--are also consis­
tently shorter than the imipramine means of the remaining 7 NS-ES 
animals (3.43, 3.04, 2.43, 2.35). In addition, one can also see 
that the 3 NS-ES saline animals escaped with longer latencies than 
the remaining 7 saline animals of this group at each block of trials.
The trials effect for Testing I was pronounced with and 
without the data of the 6 NS-ES rats, F (3,204) = 26.17; £ < .001, 
eta .55, and F (3,186) = 22.70; £ < .001; eta = .55, respectively, 
confirming that all rats learned to escape from or avoid shock across 
trials and increasing shock intensities. A significant drug x trials 
interaction, F (3,186) = 3.61; £ < .05, eta = .20 (without the 6 NS-ES 
rats), is primarily due to two trends illustrated In Figure 5. 
Imipramine animals in comparison to rats treated with saline show 
steeper learning curves between blocks 2 (0.6 mA) and 3 (0.8 mA) as 
a result of lower latency means at the higher shock intensity. Also, 
comparison of the two drug conditions at different blocks revealed 
a significant difference only at block 4 at which point imipramine 
animals were reliably faster than saline rats.
Since group treatment was not effective, a comparison of 
all Preshock (PS) groups (a combination of groups ES-IS, NS-IS, and 
NS-ES) versus a No Preshock (NPS) group (all NS-NS animals) was 
carried out for Testing I. A small, nonsignificant group effect,
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F (1,66) = 3.02; £ <  .10, reflecting the longer latencies of all 
preshocked animals, and a nonsignificant group x drug interaction,
F (1,66) = 2.66; £ < .25, were shown. There was no difference 
between drug conditions, F (1,66), £ < 1.10. When the data of 
the 6 NS-ES rats which had not learned to shut off shock in the 
restraining tubes were added to the analysis (see Table 7 and 
Figure 6), group differences, F (1,72) = 3.33; £ <  .10, and drug 
effects, F (1,72) = 1.27, were still not significant. However, a 
group x drug interaction, F (1,71) - 4.24; £ < .05; eta = .25, 
showed in the saline condition that PS animals (mean = 3.56) 
escaped with slower latencies than NPS rats (mean = 2.78; £ < .05).
On the other hand, the two groups treated with imipramine revealed 
only a small, nonsignificant difference (PS mean = 3.04; NPS mean 
= 2.97). Figure 6 reflects the performances of all four groups 
across blocks of trials. Inspection shows that at block 1, perform­
ances of PS saline animals (mean = 4.01) are significantly slower 
than those of NPS saline rats (mean = 3.01; £  < .01). However, at 
block 2, their performances (PS mean= 3.41, NPS mean = 2.98) are 
indistinguishable due to the fast improvement of PS animals. A 
divergence between their performance curves occurs again at block 3 
(PS mean = 3.38, NPS mean = 2.80; _£ < .05) which becomes even more 
pronounced at block 4 (PS mean = 3.45, NPS mean = 2.26; £ <  .01).
Testing II (nonassisted testing). Figure 5 shows that, 
except for NS-NS imipramine and NS-ES saline animals, drug conditions 
diverged progressively during the first three blocks of trials, and 
learning curves of all groups converged during the last two blocks,
42
Table 7
Phase III: PS versus NPS, Mean Escape 
Latencies in Testing I 
(seconds)
Drug
treat­
ment
Group
treat­
ment
Block of Trials Mean
1 2 3 4
Saline PS (n = 30) 4.01 3.41 3.38 3.45 3.56
NPS(n = 8) 3.07 2.98 2.80 2.26 2.78
Mean 3.54 3.20 3.09 2.86 3.17
Imipramine PS (n = 30) 3.67 3.06 2.65 2.78 3.04
NPS(n = 8) 3.90 3.09 2.58 2.29 2.97
Mean 3.79 3.08 2.62 2.54 3.01
Grand mean 3.67 3.14 2.86 2.70 3.09
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Phase III: Mean escape/avoidance latencies of PS (Pre­
shocked) and NPS (No Preshock) groups treated either with 
saline or imipramine immediately after completion of Phase 
II. The data were subjected to square root transformation.
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confirming that at the end of Testing II, all animals had reached the 
same level of performance. Consequently, only a significant trials 
effect, F (5,310) = 23.17; £ <  .001; eta = .60, was obtained, with 
drug x trials interaction, F (5,310) = 2.09; £ < .10, only approaching 
statistical significance.
Table 8 shows the mean escape latencies the Testing II of the
6 NS-ES rats which had not learned to terminate shock in Phase II.
The data illustrate, as in Testing I (Table 6), that the 3 rats 
treated with imipramine escaped with consistently shorter latencies 
than the 3 saline rats. The Table also shows that the means of 
the 3 saline rats are higher than those of the remaining 7 NS-ES 
saline rats at each block of trials. However, unlike in Testing I, 
imipramine means of the 3 rats that did not learn to terminate 
shock in Phase II were somewhat higher than those of the remaining
7 imipramine rats, except for the first and last block of trials.
Inspection of Figure 5 reveals an interesting trend. Most 
animals treated with imipramine as well as the NS-NS saline group 
show a deterioration in performance between block 4 of Testing I and 
block 5 of Testing II, which represents that point in the procedure 
at which assistance in wheel turning was withdrawn. Comparison of 
groups confirmed that imipramine rats, t - 3.64, df = 34; j> < .001, 
r k = *55, suffered greater deterioration at this point than saline
rats ( _t < 1.0, df = 34).
An analysis for preshock effects was also done for Testing 
II data (see Figure 6). However, with the exception of a clearcut 
decrease in latency across trials, none of the factors and their
45
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Interactions proved statistically significant.
Escape Failures. The mean numbers of escape failures in 
Phase III are presented in Tables 9 and 10. These failures repre­
sent those cases in which animals suffered the maximum duration (30.0 
sec) of shock. Table 9 suggests a strong drug effect, with saline rats 
failing to escape from shock more frequently (mean = 7.09) than imi­
pramine rats (mean = 2.40). Such a drug-related effect was confirmed,
F (1,62) = 7.28; £ < .01; eta = .33. There were no group or group
x drug interaction effects.
When escape failures were broken down to reflect performances 
in Testing I and Testing II (cfm. Table 10), it was revealed that 
saline animals, jt = 5.45, df = 34; £ < .001; r ^ = *70, and impramine
animals, t = 4.70, df = 34; £ < .001; r^b = .65, showed great improve­
ment between the first and last block of trials. Since blocks in
Testing I were comprised of unequal numbers of trials, the mean num­
bers of escape failures per trial are listed in Table 10 in order to 
equalize the data for Testing I and II. The Table shows that saline 
and imipramine groups experienced their highest incidence of escape 
failures at block 7 (.37 and .25 mean escape failures per trial, 
respectively). However, the lowest incidence for both groups was 
attained at different blocks. Saline animals experienced the smallest 
number of escape failures per trial (.07) at block 10 and imipramine 
animals (0) at block 4, which coincides with an increase in shock 
intensity to its maximum level of 1.0 mA. Saline and impramine means 
differed reliably at block 4, t = 2.90, df = 68; £ < .01; r ^ = -33, as
they did at block 3 (saline mean = .15, imipramine mean = .04, _t = 3.07,
Phase
Table 9
III: Mean Number of Escape Failures 
in Testing I and II (combined)
Group Drug condition-- Mean
treat­ mean number of
ment escape failures
Saline Imipra­
mine
NS-ES (n = 7) 5.86 1.00 3.43
NS-IS (n = 10) 6.50 3.10 4.80
ES-IS (n = 10) 9.60 2.90 6.25
NS-NS (n = 8) 6.40 2.63 4.52
Mean 7.09 2.40 4.75
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df = 68; _b < .01; r ^ - .35, and at all subsequent blocks of trials
(see Table 10), including block 8, reflecting in all cases the smaller 
failure deficit of the imipramine animals. However, no reliable drug- 
related differences in performances were obtained for the first and 
last two blocks of trials (see Table 10).
Table 11 shows the mean escape failures for the 6 NS-ES rats 
that did not learn to escape from shock in Phase II. Except for 
block 7, the saline means are consistently higher than the NS-ES 
saline means shown in Table 10. The mean escape failures in Testing I 
of the 3 NS-ES rats treated with imipramine are lower than those of 
the remaining 7 NS-ESimipramine rats shown in Table 10. Essentially 
no escape deficits were shown by these 10 imipramine animals in 
Testing II.
A comparison of preshock versus no preshock generated only a 
drug e ffect, F (1,66) = 6.18; p. < .05; eta = .30.
Shock' Avoidances. The mean number of shock avoidances are 
shown in Figure 7. As can be seen, the trend for imipramine animals 
to avoid shock less often than saline rats was completely reversed in 
the NS-IS group. Consequently, differences as a result of drug or 
group treatment were not significant. There was a slight but non­
significant group x drug interaction, F (3,62) - 1.70; £ < .25; eta = 
.27. A comparison of performance at blocks 7 and 10 gave little evi­
dence that imipramine animals, t = 1.85, df = 34; £ < .10 and no
evidence to indicate that saline rats, t < 1.0, had increased their 
frequency of avoiding shock at the end of testing.
A preshock analysis mirrored the findings mentioned. It
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Figure 7. Phase III: Mean number of avoided shocks by all rats. Shock 
was signalled by a 5.0 sec tone. Shocks were avoided by 
wheel turning during this warning period.
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revealed a slight but nonsignificant tendency for imipramine animals
to avoid shock less often than saline animals, F (1,66) = 1.42;
j-> < .25, and a nonsignificant group x drug interaction, F (1,66) -2.35;
£ < .25, reflecting the tendency in NPS imipramine animals to have
the greatest avoidance deficit and for NPS saline rats to avoid
shock more frequently than any other group.
Wheel Turning Responses. The total number of wheel-turning 
responses emitted in Phase III was recorded as a single sum for 
Testing I and II. Group means are shown in Table 12. As can be 
seen in the Table, imipramine animals as a group (mean = 41.01) did 
considerably less wheel turning than saline animals (mean = 61.43),
F (1,62) =6.97; p < .05, eta = .30. At the same time, latencies of 
imipramine rats tended to be shorter in Testing I than those of 
saline rats (cfm. Figure 5 and Table 4). There were no differences 
in wheel turning as a function of other factors.
Behavioral Results Summary
The main points of the results presented so far are:
1. All ES-IS rats learned to escape from shock in Phase I, 
and 14 (out of 20) NS-ES animals learned to escape in Phase II.
2. No group differences were observed in Phase III.
3. A statistically reliable group x drug interaction and 
drug effects obtained in Testing I of Phase III were primarily due 
to the data of 6 NS-ES rats which did not learn to escape from 
shock in Phase II. Their performances increased mean latencies for 
NS-ES saline rats and decreased latency means for NS-ES imipramine 
rats.
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Table 12
Phase III: Mean Number of Wheel Turning 
Responses in Testing I and II
Group
treat­
ment
Drug
Mean
wheel
Saline
condition: 
number of 
turns
Imipra­
mine
Mean
NS-ES (n = 7) 52.00 44.71 48.36
NS-IS (n = 10) 55.70 40.70 48.20
ES-IS (n = 10) 56.50 37.00 46. 75
NS-NS (n = 8) 81.50 41.63 61.57
Mean 61.43 41.01 51.22
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4. A drug x trials interaction for Testing I pointed to a 
greater reduction in mean latencies between blocks 2 and 3 in the 
imipramine condition. Also, imipramine animals escaped reliably 
faster at block 4 than saline rats.
5. Large trials effects confirmed that most rats learned 
to escape from or avoid shock during Testing I and II. There were 
no other effects in Testing II. However, it was noted that most 
imipramine rats and NS-NS saline rats deteriorated in performance 
between block 4 (Testing I) and block 5 (Testing II).
6. Comparison of Preshocked with No Preshock groups was 
made in order to assess the effect of preshock per se since behavioral 
manipulations had not been effective in this study. No significant 
group differences were obtained in either Testing I or II. A group
x drug interaction in Testing I, reflecting the tendency of imipra­
mine treatment to selectively decrease response latencies in pre­
shocked animals, was statistically significant only when the data 
of the 6 NS-ES animals were included which did not learn to escape 
from shock in Phase II.
7. Analysis of escape failures in Phase III revealed a drug 
effect. Saline rats failed to escape from shock more frequently 
than imipramine rats. Both saline and imipramine groups showed a 
reliable decline in escape failures at the end of testing, but the 
greatest improvement (no escape failures for any group) among imi­
pramine animals occurred at block 4 at which point shock intensity 
had been raised to the maximum level of 1.0 mA.
8. Comparison of shock avoidances failed to show a drug
56
effect. The observed tendency of imipramine to decrease avoidance 
responses was completely reversed in the NS-IS group. A preshock 
analysis revealed nonreliable tendencies for NPS imipramine 
animals to have the greatest avoidance deficit and for NPS saline 
rats to avoid shock more frequently than any other group.
9. Comparison of wheel turning during Testing I and II 
(Phase III) showed a drug effect. Imipramine animals did signi­
ficantly less wheel turning than saline animals.
Adrenal Weight. Mean adrenal weights, expressed in mg/100 
g of body weight, are shown in Table 13. In order to avoid that these 
values reflect the differential effects of drug treatment on weight 
gain (see Table 14), body weights recorded prior to drug treatment 
were chosen for the denominator. As can be seen in the Table, most 
adrenal weights were close to the grand mean (13.18 mg/100 g), and 
no significant effects were generated by the data. A comparison of 
PS and NPS animals failed to show reliable differences between 
group-**or drug-treatment.
Stomach Lesions. Table 15 shows the mean proportion of 
animals per group with stomach lesions. As can be seen, the grand 
mean (.22) was quite small. Only 12% of the imipramine and 31% of 
the saline rats showed evidence of ulceration. In spite of these 
low proportions, statistical analysis revealed that the drug effect 
was significant, X^ = 4.16, df = 1; p. < .05; C = .45. Especially 
within the NS-IS groups, significantly more saline than imipramine 
rats developed ulcers, X^ = 5.0, df = 1; p < .05; C =* .75. Comparison 
within the saline groups showed that NS-ES rats had a reliably higher
57
Table 13 
Mean Adrenal Weight
Group Drug condition: Mean
treat­ Mean weight mg/
ment 100 gm of
body weight
Saline Imipra­
mine
NS-ES (n = 7) 13.21 12.96 13.09
NS-IS (n = 10) 13.60 13.46 13.53
ES-IS (n = 10) 13.01 13.16 13.09
NS-NS (n = 8) 13.28 13.07 13.18
Mean 13.28 13.07 13.18
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Table 14
Body Weight Changes (Mean Percentages)
Group Drug condition: Mean weight (gm) Mean
treat- -----------------------------------------
Saline Imipramine
ment
Ini­
tial
Final Per­
cent
change
Ini­
tial
Final Per­
cent
change
NS-ES (n = 7) 395.6 386.7 -2.25 411.7 411.3 - .10 - 1.18
NS-IS (n = 10) 400.7 387.6 -3.27 405.6 406.1 + .12 - 1.58
ES-IS (n = 10) 403.4 391.7 -2.90 407.7 407.1 - •J-5 - 1.53
NS-NS (n = 8) 410.6 402.1 -2.07 405.4 408.1 + .68 - 1.53
Mean 402.6 392.0 -2.63 407.6 408.2 + .15 - 1.25
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Table 15
Mean Proportion of Rats with Stomach Ulcers
Drug Group Mean Mean Mean
condi­ treat­ propor­ number total
tion ment tion of of les­ length
rats with ions /Rat of
lesions lesions
( U x 10)
Saline NS-ES (n = 7) .43 1.7 54.7
NS-IS (n = 10) .40 2.3 147.8
ES-IS (n = 10) .40 1.0 165.0
NS-NS (n = 8) .00 0.0 0.0
Mean .31 1.3 91.9
Imipramine NS-ES (n = 7) .14 2.0 234.0
NS-IS (n = 10) 0.0 0.0 0.0
ES-IS (n = 10) .1 1.0 600.0
NS-NS (n = 8) .25 2.0 87.0
Mean . 12 1.3 230.3
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2
proportion of ulcers than NS-NS animals, X = 4.29, df = 1; £ <
.05; C = .75. Similarly, both NS-IS and ES-IS groups had developed
2
more ulcers than the NS-NS animals, X = 4.13, df = 1; £ < .05;
C - .70. Consequently, a comparison of PS and NPS groups showed a 
higher ulcer incidence in preshocked saline rats than in saline 
animals not having been exposed to shock prior to Phase III,
2
X = 4.74, df = 1; £ < .05; C = .62. It was also shown that pre­
shocked saline rats had significantly more ulcers than preshocked
2
imipramine rats, X = 7.68, df = 1;_p < .01; C = .75. However,
Preshock and No Preshock means did not differ reliably in the 
imipramine condition.
Table 15 also shows two other parameters. Whereas the mean 
number of lesions per animal (1.3) is the same in both drug conditions, 
the mean length of the lesions was considerably greater in animals 
treated with imipramine (230.3 y x 10) in comparison to saline rats 
(91.9y x 10). Photographs of typical stomach lesions of saline 
animals are shown in Figures 8, 9, and 10.
There was no evidence of lesions in the 6 NS-ES animals 
which had not learned to escape from shock in Phase II.
Intestinal Lesions. Since intestinal lesions as a depen­
dent variable were added to this study after the experiment had 
already begun, the total number of animals examined (34) was com­
paratively small. Table 16 shows that 45% of all imipramine ani­
mals had developed intestinal lesions as compared to only 6% (1 
ES-IS animal) of the saline rats. This drug-related difference
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Figure 8. Photographs of stomach specimens:
A. NS-IS (Saline) rat number 59. Fundus shows two lesions. 
Lesion number 1 (located in the vertical plane) measures 
2520 p; lesion number 2 (located in the horizontal plane) 
measures 1080 p.
B. NS-IS (Saline) rat number 77. Lesion is located in fundus 
and measures 2160 p.
62
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Figure 9 Photographs of stomach specimens:
NS-ES (Saline) rat number 20. Lesion is located in fundus 
and measures 1080 y.
NS-IS (Saline) rat number 30. Lesion is located in fundus 
and measures 2880 y (in diameter).
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Figure 10. Photographs of stomach specimens:
A. ES-IS (Saline) rat number 48. Perforated ulcer in fundus.
Lesion was photographed from outside of stomach wall; it 
measures 10,800 y in diameter, including edema.
B. NS-ES (Saline) rat number 63. Lesion is located in rumen;
measures 450 y in diameter, including edema.
66
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Table 16
Mean Proportion of Rats with Intestinal 
Ulcers
Drug Group Mean Mean Mean
condi­ treat­ propor­ number total
tion ment tion of of les- length
rats with ions/Rat of
lesions lesions 
( U x  10)
Saline NS-ES (n = 6) 0.00 0.00 0.0
NS-IS (n = 4) 0.00 0.00 0.0
ES-IS (n = 4) 0.25 1.00 75.0
NS-NS (n = 2) 0.00 0.00 0.0
Mean 0.06 0.25 18.8
Imipramine NS-ES (n = 5) 0.40 2.00 55.0
NS-IS (n = 5) 0.80 1.30 113.8
ES-IS (n = 5) 0.60 1.00 90.0
NS-NS (n = 3) 0.00 0.00 0.0
Mean 0.45 1.08 64.7
68
2
was highly significant, X = 7.82, df = 1; £ < .01; C = .80. The 
effect was particularly pronounced in preshocked animals; 60% of 
rats treated with imipramine had intestinal lesions, compared to
2
only 8% of the saline rats, X = 8.97, df = 1; £ < .01; c - .80.
A differential effect of the drug treatment was also noted for 
the NS-IS rats, with 80% of the imipramine animals of this group 
having developed ulcers, compared to none of the saline rats,
2
X = 5.78j df = 1; £ < .02; C = .80. Within the imipramine condi­
tion, significantly more NS-IS rats had ulcers than NS-NS rats,
X2 = 4.8, df = 1; £ < .05; C = .80.
As in the case of stomach lesions, no intestinal lesions 
were found in the 6 NS-ES animals.
Food Consumption. The amount of food eaten over a period of 
24 hours following shock treatment in Phase II is recorded in 
Table 17. A reliable group difference, F (3,62)' = 2.78; £ < .05; 
eta = .35, confirmed that food consumption varied as a function of 
behavioral treatment. Pairwise comparisons of means showed that 
NS-ES rats (mean = 19.2 gm) ate the least, and that NS-NS animals 
(mean = 23.3 gm) ate the most food (£ < .05).
However, in addition it was found that the animals' eating 
behavior was also influenced by the drug treatment they received,
F (1,62) = 55.87; £ < .001; eta = .70. While saline animals con­
sumed essentially 1007. (24.9 gm) of their food, imipramine rats 
ate considerably less (17.3 gm) . There was a tendency for the drug 
effect to be selective. Group x drug interaction, F (3,62) = 2.42;
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Table 17 
Food Consumption (Mean gm)
Group
treat­
ment
Drug condition Mean
Saline
•(gm)
Imipra­
mine
(gm)
NS-ES (n = 7) 24.7 13.6 19.2
NS-IS (n = 10) 24.9 16.6 20.8
ES-IS (n = 10) 24.9 17.5 21.2
NS-NS (n = 8) 25.0 21.5 23.3
Mean 24.9 17.3 21.1
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£ <  .10 approached statistical significance. However, when all pre­
shocked animals were compared to NPS animals, the group x drug inter­
action, F (1,66) = 4.76; £ <  .05; eta = .25, revealed that imipramine 
decreased food consumption only in preshocked animals (see Table 18).
Water Consumption. The amount of water consumed by each 
group over a period of 24 hours following shock treatment in Phase II 
is recorded in Table 19. Inspection of the Table reveals that imi­
pramine animals drank less water than saline rats which was confirmed 
by analysis of variance, F (1,62) = 11.37; £ < .01; eta = .40.
However, differences in water consumption as a function of group treat­
ment or as a result of group x drug interaction failed to reach signi­
ficance .
Body Weight Changes. Body weights were monitored for a period 
of 48 hours from the time of shock termination in Phase II to autopsy 
immediately following completion of Phase III. Changes in body weight 
(mean percentages) are recorded in Table 14. As can be seen in the 
Table, there was a tendency for saline animals to lose weight 
(-2.637o) and for imipramine animals to gain weight (4- .15%). This 
drug effect was confirmed by analysis of variance, F (1,62) = 21.60;
£ < .001; eta = .50. No other reliable treatment differences on body 
weight were noted.
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Table 18
Mean Food Consumption (PS versus NPS)
PS
NPS
Mean
Group Drug condition Mean
treat- --------------------
Saline Imipra-
ment
(gm) mine
(gm)
(n = 27) 24.85 16.15 20.50
(n = 8) 25.00 21.50 23.25
24.93 18.83 21.88
Group
treat­
ment
NS-ES (n = 
NS-IS (n = 
ES-IS (n = 
NS-NS (n = 
Mean
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Table 19 
Water Consumption (Mean ml)
Drug condition Mean
Saline Imipra-
(ml) mine
(ml)
7) 56.9 41.6 49.3
10) 58.9 45.5 53.2
10) 55.4 51.5 53.5
8) 55.1 40.1 47.6
56.6 44.7 50.7
Chapter 4 
Discussion
The results of this investigation show that manipulation of 
control over adverse circumstances, in the form of inescapable shock, 
had no effect on escape/avoidance latencies in Phase III. Rats 
treated with saline terminated shock by wheel turning with similar 
latencies, regardless of the fact that they had been trained pre­
viously with escapable shock in Phase I (ES-IS) or in Phase II 
(NS-ES); that they had experienced only inescapable shock prior to 
wheel turning (NS-IS), or that they had not been exposed to prior 
shock in Phase I or II (NS-NS). Consequently, the hypotheses that 
performances in Phase III of NS-ES and ES-IS saline rats would be 
superior to those of NS-IS saline rats had to be rejected.
When escapability as a condition was put aside and only shock 
treatment (preshock) prior to Phase III was examined, the behavioral 
data indicated that preshock per se had been an effective manipula­
tion only in Testing I of Phase III with the inclusion of the data 
of those 6 NS-ES rats (3 in each drug condition) which had not learned 
to escape from shock in Phase II. Their performances in Phase III 
increased escape/avoidance latency means for NS-ES saline animals 
and decreased these means for the NS-ES imipramine group (cfm.
Tables 4 & 5). As a result, mean escape/avoidance latencies of 
preshocked (PS) saline animals in Testing I (but not in Testing II) 
were longer than those of saline rats (NPS) which had not been
73
74
preshocked. Since preshock had not produced increased latencies 
among PS animals treated with imipramine, it appeared that the drug 
had attenuated in Testing I the deficits in escape/avoidance 
responding associated with preshock.
Most other behavioral changes in Phase III could also be 
attributed to the effects of imipramine which, in comparison to 
saline, produced greater improvement of performances across trials 
and increasing shock intensities during assisted training (Testing I) 
and reduced escape failures in Testing I and II. In view of these 
drug-related improvements, the hypothesis predicting the superior 
performances in Phase III of NS-IS imipramine rats to those of 
NS-IS saline animals had to be rejected. Similarly, the hypotheses 
that performances of NS-ES and NS-NS imipramine rats would be inferior 
to those of their counterparts in the saline condition had to be 
rejected as well.
Physiological data agreed with the behavioral results. No 
consistent group effects reflecting shock escapability were revealed 
across the variety of physiological symptons monitored. However, 
preshock in the saline condition was associated with a higher inci­
dence of stomach ulcers than was lack of experience with prior 
shock (NPS). Since preshocked animals treated with imipramine did 
not differ in this respect from imipramine NPS rats, the data suggest 
that the drug attenuated the pathogenesis of stomach ulcers in pre­
shocked rats. Other drug effects on physiological functions included 
a high incidence of intestinal ulceration, increases in body weight, 
and decreases in food and water consumption, most of which were
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identifiable as side effects of imipramine associated with its acute 
administration schedule. The point remains, however, that there 
were no consistent group effects reflected in behavior or physio­
logical functioning which could be attributed to a manipulation of 
control over shock.
Procedural Variations
The discussion which follows will consider some procedural 
variations which may account, in part, for the inconclusive results.
1. No performance deficits were observed in NS-IS rats 
during escape/avoidance testing in Phase III. To obtain perform­
ance deficits with rats (in comparison with dogs) when using the 
learned helplessness paradigm appears to require that one adhere 
strictly to established procedures, since even slight procedural 
variations may result in failure to replicate the deficit (Freda & 
Klein, 1976). In this study, a new procedure was introduced which 
consisted of allowing inescapably shocked rats to make nonrewarded 
responses in Phase II which were identical to the rewarded responses 
(nose pokes) made by the escaping NS-ES group. It was hoped that 
this procedural change would help clarify the role played by con­
tingency in producing learned helplessness, since most previous 
studies had never satisfactorily demonstrated nor defined the condi­
tions of noncontingency in inescapable shock treatment. The results 
(Table 3) showed that NS-IS rats made fewer nose pokes (82) in the 
restraint than NS-ES rats (198) who were consistently rewarded with 
shock termination. The only other study (Kelsey, 1977) which has 
since looked at responses emitted during inescapable shock treatment 
found that inescapably shocked rats which were allowed to make 
nonrewarded wheel turns showed larger performance deficits in
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subsequent FR-2 escape/avoidance shuttling than other inescapably 
shocked rats whose wheels had been locked. Kelsey interpreted these 
findings within the framework of the learned helplessness hypothesis 
and argued that animals allowed to make responses during inescapable 
shock treatment which were qualitatively similar to subsequent 
escape/avoidance responses had a greater opportunity to learn that 
their responses were uncorrelated with shock termination than rats 
who had their wheels locked.
It is possible that in this study, the inescapably 
shocked NS-IS rats may not have learned that their responses 
failed to result in shock termination. Inspection of Figure 4, 
for example, shows that their response rates, especially in compari­
son to those of the ES-IS animals, continued to increase up to trial 
72 (T72), suggesting that nose poking was reinforced in these ani­
mals. However, their relatively low rates, in comparison with those 
of NS-ES animals who received consistent reinforcement, suggest that 
the reinforcement regime for the NS-IS rats was not consistent.
This may have been the result of inconsistent reward (shock may have 
been terminated also in the absence of nose poking) as well as of 
occasional punishment of the coping response (for example, nose 
poking may have coincided at times with shock onset), which would 
have created a response conflict. The fact, however, remains that, 
except for the first 24 trials, NS-IS animals emitted more than one 
nose poke per trial, making it conceivable that nose pokes and shock 
termination coincided frequently enough to establish a spurious
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contingency, especially considering that the average shock duration 
was only 2.2 sec. In other words, intermittent reinforcement may 
have operated to shape superstitious behavior which could have pre­
vented NS-IS animals from learning that what they did had no effect 
on shock termination.
It is, of course, possible to interpret these findings 
within the framework of response competition theory (Bracewell & 
Black, 1974; Glazer & Weiss, 1976a, 1976b; Lewis, 1976), according 
to which one might argue that nose poking acquired in Phase II 
was incompatible with wheel turning required in Phase III. However, 
there was no evidence pointing to the fact that the performances 
in Phase III of NS-ES and NS-IS animals were inferior to those of 
NS-NS rats who had not had an opportunity to learn responses which 
might later interfere with wheel turning. By the same token, ES-IS 
rats which did not learn to nose poke failed to show an advantage in 
Phase III, unless one assumes that this group was equally handi­
capped with response competition because of the FR-1 shuttling 
responses it had acquired in Phase I. In order to elucidate the 
exact mechanisms that are at the root of learned helplessness, 
these results emphasize the need for careful examinations of those 
behaviors exhibited by animals during inescapable shock treatment.
2. In addition to the procedural innovation mentioned 
here, there is also the parametric variable of mean duration of 
shock which may influence the development of performance deficits 
associated with learned helplessness. Such a possibility had 
already been raised by Glazer and Weiss (1976a [ Experiment 2 ];
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1976b). According to the authors, long duration (5 sec), moderate 
intensity (1.0 mA) tail shock is biphasic in nature, producing a 
peak of motor activity at the time of shock initiation, followed 
by a decline in movement as shock continues (see also Anisman, 
deCatanzaro, 6c Remington, 1978). Such a course of events reinforces 
passive behavior with shock termination which, in turn, is incom­
patible with any active motor responses demanded in a subsequent escape/ 
avoidance task. However, the possibility of conditioning passive 
behavior as a consequence of biphasic preshock had been anticipated, 
and shock in Phases II and III was, therefore, programmed to be 
delivered in short pulses which resulted in no apparent behavior pat­
terns at the time of shock termination.
Moreover, preshock in this study lasted on the average 
only 2.2 sec, a duration which was determined by the mean latency 
of the escaping animals. On the other hand, many published studies 
(Maier, Albin, 6c Testa, 1973; Seligman, Rosselini, & Kozak, 1975; 
Williams 6c Maier, 1977) which reported helplessness effects in rats 
did not use a control group that could escape from shock. This 
meant that inescapably shocked rats received the maximum duration of 
shock (from 5 to 15 sec, depending on the study) on every trial.
Those studies which did use an escape group report a mean shock 
duration for their escape and yoked groups from 3.8 sec (Kelsey,
1977) to 4.2 sec (Seligman 6c Beagley, 1975 [ Experiment 1 ]). It 
is, therefore, possible that the short durations of shock experienced 
in Phase II of this study were insufficient to produce associative 
or nonassociative deficits that could become manifest in Phase III.
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3. No differential effects on escape/avoidance behavior 
in Phase III were observed in ES-IS rats which had received training 
with escapable shock in Phase I. In accordance with Seligman1s 
theory (Seligman, Rosselini, & Kozak, 1975), it had been hypothe­
sized that prior experience with escapable shock should proactively 
interfere with the subsequent learning by ES-IS rats in Phase II 
that responding and shock termination are independent. Such inter­
ference with learning of helplessness was expected to reduce in 
Phase III the behavioral deficits usually associated with prior uncon­
trollable shock treatment. However, since NS-IS controls failed to 
show performance deficits in Phase III, this hypothesis could not 
be tested.
Some indication of the effects of prior experience with 
controllable shock on ES-IS rats was given by their behavior in 
Phase II. In comparison with the NS-IS rats, who were also inescap­
ably shocked, ES-IS animals did not nose poke very much (cfm. Table 
3 and Figure 4). These findings are, for example, inconsistent with 
results obtained with dogs (Seligman & Maier, 1967). The study 
reported that dogs which had first learned to escape shock in the 
shuttle box pressed the panel four times as often as did naive dogs 
during subsequent inescapable shocks in the harness (panel pressing, 
in this case, is analogous to nose pokes). However, ES-IS animals, 
unlike the other rats, did not move and struggle a lot during shock 
in the restraining tubes, but crouched and apparently froze for the 
entire session. Freezing, according to Bolles (1970), is the pre­
potent response in the rat's repertoire for defensive reactions, and
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this response must be suppressed before instrumental responses of 
shock avoidance (or escape), which are lower in the rat's response 
hierarchy, can be learned (Anisman & Waller, 1973). Persistent 
freezing in rats has been associated with high emotionality 
(Broitman & Donoso, 1978; Levine, Madden, Conner, Moskel, &
Anderson, 1973) which probably interferes with the modification 
of response hierarchy changes that facilitate instrumental respond­
ing in the presence of stress. The observed behavior of the ES-IS 
rats strongly suggests that rather than reducing maladaptive emo­
tionality to inescapable/uncontrollable shock in Phase II, their pre­
vious experience with escapable shock in Phase I appeared to have 
augmented the aversiveness of shock.
One explanation for these results addresses the degree 
of difficulty involved in FR-1 shuttling. Investigators (e.g.,
Maier, Albin, & Testa, 1973), who have examined one-way crossings 
in the shuttle box, concluded that because short latency shuttling 
appears in rats from the very first trial, it might be a very high 
probability initial response to shock, perhaps a species-specific 
defense response as discussed by Bolles (1970). Such a conclusion 
was supported by the data here. Mean latency at block I in Phase I 
was 1.9 sec (see Figure 2) which increased to a peak of 2.9 sec at 
block II and decreased to 1.3 sec by the end of testing, confirming 
that short latency shuttling was acquired very quickly and was main­
tained throughout most trials.
A more systematic examination of the influence of task 
requirements on performance was recently made by Jackson> Maier,
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and Rapaport (1978) who showed that shock intensity may interact with 
the level of difficulty of a task, and that together both variables 
affect the performances of rats. For example, they showed that high 
shock levels (1.0 mA) elicit motor activity which facilitates FR-1 
and even FR-2 crosses, even in preshocked animals. However, this 
shock-elicited motor behavior is not sufficient for rats to perform 
a more complicated task, such as FR-3 crosses in a shuttle box. The 
authors suggested that rats required to make FR-1 or FR-2 crosses at 
shock levels of 1.0 mA may well perform well but actually learn little 
about the response-outcome contingency.
The likelihood that ES-IS animals did not learn about the 
response-outcome contingency in Phase I, however, does not account 
for their lack of nose poking in Phase II. Perhaps it could be 
argued that, in accordance with response competition theory, these 
animals learned a very active response (FR-1 shuttling) in Phase I 
which was incompatible with the more passive but controlled response 
(nose poking) available in Phase II. It may be recalled that, 
according to Seligman*s model, the incentive for the initiation of 
active responding in the presence of electric shock or other aver- 
sive treatments is partly produced by the expectation that responding 
will increase the probability of shock termination (Maier, Seligman,
6c Solomon, 1969). It is possible that species-specific defense 
responses or behavior which is readily elicited by the environment 
and does not require any learning, do not produce the expectations 
that responding will reduce aversive outcomes. The argument made 
here suggests that incompatible motor responses may be important in
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interfering with a subsequent response acquisition only when the 
learning of expectancy (that one is able to mitigate aversive 
experience) has been short-circuited by the substitution of 
readily elicited motor responses which require little or no learning.
4. Another procedural variation employed here which may be 
partly responsible for obliterating potential group effects in 
Phase III was the training procedure used in Testing I to shape 
wheel turning. Pilot work had shown that the limited surface area 
of the wheel available for turning (see Figure 1) made escape/ 
avoidance responding too difficult, and shaping was used to fender 
the task sensitive to deficits resulting from control over shock 
rather than from other factors. However, it seems that controlling 
the amount of wheel turning in addition to escalating shock inten­
sity gradually for a third of the testing session may have consti­
tuted too much assistance. In fact, it has recently been shown 
(Maier & Jackson, 1977) that short latency wheel turns occur in rats 
from the outset of training and that acquisition can be made more 
difficult by counting only those wheel turns which are completed more 
than 0.8 sec after onset of shock (Jackson et al., 1978).
Considering that the ability to learn that shock could 
be escaped or avoided was the index of helplessness and as such 
the most critical measure in this study, the assistance given to the 
animals in this task may have masked any potential effects of the
previous treatments and prevented the manifestation of helplessness 
in Testing II.
5. Summary of procedural variations--the discussion centered 
on procedural variations that may account, in part, for the 
ineffectiveness of control over shock as a behavioral manipulation.
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For example, the fact that NS-IS rats were allowed to make non­
rewarded responses in the restraining tubes (Phase II) and were 
exposed to shock that, on the average, lasted only 2.2 sec, may 
have created conditions which did not promote the learning that 
shock was inescapable (and as such, uncontrollable). On the other 
hand, it is also possible that the unrewarded nose pokes emitted 
in Phase II may have provided a greater opportunity for these ani­
mals to learn that shock was uncontrollable, but that associative 
behavior deficits could not be manifested in Phase III because of 
the extensive assistance provided during Testing I.
With regard to ES-IS rats, it was suggested that FR-1 
shuttling in Phase I, because it was acquired so quickly, may have 
constituted species-specific defense responses or shock-elicited 
motor activity which required little or no learning. These findings 
were also interpreted within the framework of response competition 
theory, and it was argued that FR-1 shuttling acquired in Phase I 
may have been incompatible with nose poking in Phase II. It was 
suggested that response competition may be a factor in producing 
learned helplessness in those cases in which learning the expecta­
tion that responding mitigates aversive outcomes is prevented by 
easy task requirements.
Again, as in the case of NS-IS rats, the extensive shaping 
used in Testing I may have masked the manifestation of associative 
or nonassociative behavior deficits in ES-IS rats that were sug­
gested by the passive behavior exhibited in Phase II.
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Imipramine Effects on Behavior 
Imipramine treatment had been included in this study because 
of the drug's known antidepressant activity (Goodman & Gilman, 1977) 
and because of its reputedly deleterious effects on the test perform­
ances of nondepressed humans and animals (DiMascio, Heninger, & 
Klerman, 1964; Goodman & Gilman, 1977; Sulser, Watts, & Brodie,
1962). It had been hoped that such selective action might occur in 
differentially treated rats, allowing some speculation about the bio­
chemical states associated with different treatments of escapability. 
Ultimately, it was hoped that selective effects of imipramine would 
allow one to test the adequacy of learned helplessness as a model 
for human depression.
However, the only selective action on behavior which was 
produced by imipramine in this study was an initial attenuation in 
Testing I of long response latencies associated with prior shock expo­
sure (preshock). The effect, however, was tenuous since it depended 
on the data of the 6 NS-ES rats which had failed to learn the shock- 
terminating response in Phase II. The other major drug-related 
influences on behavior, reduction of escape failures in Testing I and 
II, as well as greater improvement of performances across trials and 
increasing shock intensities in Testing I, affected all animals 
treated with imipramine, regardless of their experimental histories.
The fact that drug-induced changes of behavior were obtained 
in the absence of helplessness or depression suggests that these 
effects of acute drug administration cannot be understood in terms 
of an antidepressant action. This issue, whether and how the acute
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effects of tricyclics are related to the antidepressant mechanism, 
has also been raised in more clinically-oriented research (Barchas, 
Patrick, Raese, 6c Berger, 1 9 7 7 ;  Jones, Howard, 6c McBennett, 1 9 8 0 ;  
Mandell, 1 9 7 5 ;  Schildkraut, 1 9 7 5 ,  1 9 7 7 ) .  Since only chronic treat­
ment with tricyclics, for a minimum of 1 0  to 1 4  days, produces an 
abatement of depressive symptomatology, it was suggested (Mandell, 
1 9 7 5 ) ,  for example, that the clinical efficacy may be due to 
secondary or tertiary adaptive mechanisms set in motion by the 
primary, acute drug effects.
Instead then of being able to attribute the alterations of 
behavior produced by imipramine to an antidepressant action, theories 
were presented in subsequent portions of this paper which ascribed 
drug-induced changes of behavior following uncontrollable trauma 
to the mediation of either associative or nonassociative processes.
For example, the possibilities that memory processes, mood states, 
motor activity, sensitivity to pain, or arousal mechanisms were 
impaired by shock treatment and subsequently restored to normal 
functioning by imipramine were evaluated.
The discussion which follows will first look at central trans­
mitter activity which might have been modified by imipramine and then 
consider the processes which may have mediated the changes in per­
formance observed in Phase III.
Attenuation of behavior deficits associated with preshock. 
Saline animals pretreated with shock (ES-IS, NS-IS, NS-ES) required 
more time to turn off shock by wheel turning during Testing I than 
no-shock controls (NS-NS) also treated with saline. However, this
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preshock effect was significant only with the data of the 6 NS-ES 
saline and imipramine animals (3 in each drug condition) mentioned 
previously. Since similar response deficits did not occur in pre­
shocked imipramine rats, the data suggest that the drug attenuated 
long latencies associated with prior exposure to shock.
The reduction of preshock-induced performance decrements 
mediated by imipramine can probably be understood best when one 
considers the drug's role in modifying biogenic amines since central 
changes in activity and/or net levels of various neurotransmitters 
have been cited as being important in shock-mediated behavior 
deficits. For example, it has been shown that imipramine inhibits 
the reuptake of norepinephrine (NE), serotonin (5-HT), and dopamine 
(DA) (Randrup 6c Braestrup, 1977), and ample data exist which show 
that these transmitters are affected by preshock.
With respect to adrenergic changes, it has been reported 
(Anisman 6c Sklar, 1979 ; Bliss, Ailion, 6c Zwanziger, 1968; Bliss 6c 
Zwanziger, 1966; Maynert 6c Levi, 1964; Weiss, Glazer, Pohorecky, Brick, 
6c Miller, 1975), that inescapable shock which is sufficiently intense 
reduces brain levels of NE, presumably because under such circum­
stances NE utilization exceeds synthesis (Anisman, 1978). Recovery 
of normal NE levels in the brain has been reported to require from 
1 to 6 hours (Barchas 6c Freedman, 1963; Maynert 6c Levi, 1964;
Paulson 6c Hess, 1963). Furthermore, remarkable parallels are said 
to exist between pharmacological treatments (such as FLA-63, for 
example), which selectively deplete central NE and interfere with 
subsequent escape/avoidance performance, and inescapable shock (Anisman,
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Remington, & Sklar, 1979; Kelsey, 1977; Weiss, Glazer, &
Pohorecky, 1976). These findings would suggest that if associative 
factors are involved in performance deficits, they would be partly 
mediated in rodents by significant reductions of central NE.
While changes in turnover and net levels of NE may be pro­
foundly affected by prior shock, central changes of DA levels 
are considerably less dramatic. However, this lack of responsive­
ness to shock of DA levels has been related (Bliss et al., 1968) to 
a rapid resynthesis of central DA (and serotonin) at a rate that 
is considerably faster than that of NE. Nevertheless, it has been 
demonstrated (Anisman, Remington, & Sklar, 1979) that selective 
depletion of DA by haloperidol or pimozide produced a dose-dependent 
disruption of performance when the subsequent escape paradigm involved 
protracted shock during which vigorous motor activity had to be sus­
tained .
There have, to date, not been any systematic investigations 
evaluating the effects of different shock parameters on the activity 
of central serotonin. However, the potential role of this trans­
mitter in subserving the escape interference cannot be dismissed 
(Anisman, Remington, & Sklar, 1979). For example, it has been 
shown (Thierry, 1973; Welch &. Welch, 1970) that inescapable stress 
reduces 5-HT levels and that pharmacological manipulations of 5-HT 
modify escape/avoidance responses (Lorens, Gulberg, Hole, Kolater,
& Srebro, 1976).
Findings like these suggest that the biochemical effects of 
prior shock may result from complex interactions involving at least
these two transmitter systems (adrenergic and serotonergic) and possi­
bly a third (cholinergic) as well. For example, Anisman (1975) has des 
cribed a likely chain of neurochemical events that may follow an 
initial stress situation. He hypothesized that exposure to shock may 
result in increased catecholamine (NE and DA) activity, followed by 
a compensatory cholinergic rebound which produces behavioral inhibi­
tion (Carlton, 1969). Moreover, after the initial catecholamine 
excitation, catecholamine activity declines, thus exacerbating the 
inhibitory effects of the cholinergic reaction. In view of these 
complex interactions, it is reasonable to assume that imipramine 
action on central neurochemical imbalances induced by preshock may 
affect not only adrenergic and serotonergic systems but also central 
cholinergic activity. Such a conclusion was reached by Janowski, 
El-Yousef, Davis, and Sekerke (1972) who stated that tricyclic 
antidepressants (including imipramine) block central cholinergic 
activity in addition to increasing functionally available adrenergic 
neurotransmitters, thus shifting the adrenergic-cholinergic balance 
toward an adrenergic predominance.
The explanations offered for the drug-induced attenuation 
of the escape deficit in preshocked animals have, so far, only dealt 
with the potential neurochemical correlates of the deficit that might 
have been modified by the drug, but not with the possible processes 
that may mediate the observed changes in behavior. Even though this 
study was not designed to test whether imipramine affected associa­
tive (e.g., learning and memory) or nonassociative (e.g., motor 
activity, motivation) processes, the issue will be briefly considered
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here.
Many investigators who have observed performance decrements 
following preshock in rodents have interpreted these changes mostly 
in terms of nonassociative processes. For example, some theorists 
(Weiss & Glazer, 1975) have suggested that such deteriorations of 
performance are due to a motor activation deficit, produced by 
the lowered NE level in the brain, which hinders escape when vigor­
ous and sustained responding is required in the presence of shock 
/Anisman, Remington, 6c Sklar, 1979). Therefore, the argument con­
tinues, the preshock-induced escape interferences can be inter­
preted more parsimoniously in terms of a deficit in maintaining 
motor activity rather than by associative theories like learned 
helplessness (Anisman, deCatanzaro, & Remington, 1978; Glazer, Weiss, 
Pohorecky, & Miller, 1975; Weiss & Glazer, 1975; Weiss, Glazer, 6c 
Pohorecky, 1976; Weiss, Glazer, Pohorecky,Brick 6c Miller, 1975).
In accordance with such a theory, one could hypothesize, for example, 
that imipramine in this study attenuated performance deficits by 
enabling preshocked animals to initiate and/or maintain motor 
responses in the presence of shock. The conceptual problem of how 
such apparently transient imbalances can influence behavior long 
after they have been corrected has been handled by different investi­
gators outside the framework of cognitive theory. For example, it 
has been suggested (Levine et al., 1973; Pappas 6c Gray, 1971;
Vertes &. Miller, 1976) that biochemical states may come under stimu­
lus control. Moreover, it has been shown (Keim 6c Sigg, 1976) that 
transmitter levels are subject to sensitization effects. Accordingly,
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it may be envisioned that after previous exposure to shock, the 
reintroduction of the stressor may come to elicit an exaggerated and 
rapid neurochemical change manifested, after 5 to 8 trials (Anisman, 
Remington, 6c Sklar, 1 9 7 9 ) ,  which is subject to modification by acute 
drug action.
However, since the completion of this investigation (1977), 
some recent studies (Leshner, Remler, Biegon, 6e Samuel, 1979; Porsolt, 
Anton, Blavet, 6c Jalfre^ 1978) have suggested that other processes 
may be involved in the impairment of behavior induced by prior aver- 
sive stimulation which is not controllable. Both studies reported 
an alleviation of such impairment through the treatment with anti­
depressants.
The first study was part of a series of experiments which 
showed that behavior decrements associated with prior inescapable 
shock could be erased by fornix lesions (Leshner 6c Segal, 1978) as 
well as by intraventricular injections of antivasopressin (Leshner, 
Hofstein, Samuel, 6c Greidanus, 1979). According to the authors, the 
results suggested that preshock and, by analogy, learned helpless­
ness exert their effects through processes involved in long-term 
memory which, in turn, may be mediated by central catecholaminergic 
systems. A subsequent study (Leshner, Remler, Biegon, 6c Samuel, 1979), 
which was done in the same laboratory with the equipment and experi­
mental parameters used in the previous two experiments, showed that 
treatment for 1 week with the imipramine metabolite DMI (desmethyl- 
imipramine), which was initiated immediately after preshock, not only 
erased subsequent performance deficits, but did so in a dose-dependent
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manner. These results invited the speculation that one way imipramine 
and its metabolites may attenuate escape/avoidance deficits is by 
acting as a memory blocker. Such an interpretation found some ten­
tative support in another study (unpublished data) in which chronic 
DMI treatment was started 24 hours following inescapable shock treat­
ment. Under those circumstances, DMI did not alleviate preshock- 
induced response impairment. Apparently, consolidation processes, 
which are influenced by the posttrial administration of drugs (McGaugh,
1966) had already been completed, and memory traces could no longer 
be modified by DMI. Since in the majority of cases, it is decreased 
levels of central NE which have been associated with impaired memory 
functioning (Anlezark, Crow &c Greenway, 1973; Hall, 1976), whereas 
increased NE levels have been implicated in the improvement of memory 
(Castellano, 1977; Henry, Weingartner, & Murphy, 1973), it is con­
ceivable that endogenous levels of NE in the brain were decreased 
by the chronic administration schedule of DMI. Such an outcome, for 
example, was shown by Schildkraut (1975) with imipramine, who found 
that NE levels in the brain were significantly decreased by chronic 
(3 weeks) administration of the drug. In view of the fact that acute 
administration of imipramine, which was used in this study, is known 
to increase levels of central NE (Axelrod, Whitby, 6c Hertting, 1961), 
it is unlikely that memory processes were involved in mediating the 
improved performances following preshock in animals treated with 
the drug.
The second study (Porsolt, Anton, Blavet, 6c Jalfre^, 1978) 
raised the possibility that antidepressants, including imipramine,
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attenuated performance deficits in rats which result from prior 
inescapable aversive stimulation through changes of mood which are 
reflected in more vigorous motor responses. Prior to drug treat­
ment, animals were subjected to an inescapable swim which typically, 
after a 24-hour interval, produced an immobile posture in a subse­
quent swimming task. Immobility was reduced by a series of 3 i.p. 
injections of imipramine or other antidepressants in a dose-dependent 
manner at doses which otherwise decreased spontaneous motor activity. 
The authors concluded that immobility reflects a state of lowered 
mood in the rat which is selectively sensitive to antidepressant 
drug treatments as well as to nonpharmacological treatments as electro- 
convulsive shock, deprivation of REM sleep, and exposure to an 
enriched environment. They interpreted their findings as providing 
pharmacological evidence for a link between learned helplessness 
and depression.
These studies suggest at least two different processes through 
which preshock and imipramine may have mediated their (opposite) 
effects- It is possible that preshock reduced the ability of rats 
to initiate and/or maintain protracted motor activity in the pre­
sence of shock, a deficit which was attenuated by imipramine.
Similarly, the possibility that preshock and imipramine may have 
affected mood states cannot be ruled out. However, examining the 
data (Figure 5) of Phase III, shows that the preshock effect did not 
carry over into Testing II. This tendency for the performances of 
preshocked rats to improve over trials is in contrast to the data 
reported in other studies (Glazer & Weiss, 1976b; Kelsey, 1977;
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Maier & Testa, 1975). These investigators found, for example, that 
the inescapably shocked rats frequently escaped as well as the con­
trols on the first few trials, but tended to become increasingly 
slower as the session progressed. Such differences in the time 
course suggest that the preshock phenomenon in this experiment may 
have been qualitatively different from the shock-induced behavior 
changes reported in the other studies. Moreover, it is likely that 
the nature of the preshock effect in Testing I was partly determined 
by the nature of the deficit that produced the long latencies of the 6 
NS-ES animals in Phase II on whose subsequent performances in Phase III 
the preshock effect was dependent. The fact that imipramine was able 
to reduce these latencies in the 3 NS-ES rats treated with the drug
rules out the possibility that intelligence factors were responsible
for the animals’ failure to perform in Phase II. In comparison to 
the majority of the NS-ES rats, Table 2 shows that the escape latencies 
of the 6 animals were consistently higher already at the first few 
blocks of Phase II when the rats were still relatively naive and 
their central transmitter levels presumably not yet significantly 
reduced by shocks they could not control. Their latencies continued 
to remain high for the entire session. This pattern of early deteri­
oration of performance indicates that the inability to terminate 
shock did not result from exhaustion either. Rather, these data sug­
gest that the 6 animals may have brought to the shock situation cer­
tain innate tendencies as, for example, low thresholds for arousal or 
pain, which handicapped their escape efforts in Phase II and in 
Testing I of Phase III as well. Imipramine treatment, on the other
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hand, was able to mitigate these tendencies in Testing I and II at 
all blocks of trials (cfm. Tables 6 and 8). The speculation 
expressed here is that these innate tendencies helped shape the pre­
shock effect in Testing I, but that the extensive shaping procedure 
and the relative ease with which wheel turning is acquired by rats 
(Jackson et al., 1978) reduced the functional importance of these 
handicaps and eventually enabled all preshocked rats to escape from 
shock in Testing II.
Whereas the possibility implied earlier that analgesic pro­
perties of imipramine may have facilitated escape responding will 
be discussed briefly in a subsequent section, a more detailed account 
of another mechanism through which imipramine may have attenuated 
innate as well as externally produced high levels of arousal will 
be outlined also.
It has been reported (Hamburg, Hamburg, & Barchas, 1975) 
that serotonin systems in the brain play a crucial role in regulating 
selective responsiveness to environmental stimulation. More speci­
fically, it was proposed (Swonger 6c Rech, 1972) that serotonin modu­
lates high levels of arousal by strengthening selective inhibition 
of those sensory inputs or motor outputs which do not have any adap­
tive significance in a particular situation. In accordance with the 
gain-setter model (Swonger 6c Rech), selective inhibition is con­
trolled by the serotonergic neurons of the raphe system which maintain 
a balance between the limbic-based cholinergic inhibitory processes 
and the facilitatory adrenergic mechanisms of the reticular arousal 
system. According to this hypothesis, any deficits in serotonergic
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processes are apparent only when no elevated inhibitory function is 
required. In moderate or low arousal states, the cholinergic inhibi­
tory system would function adequately to maintain the selectivity 
of responsiveness. This prediction is borne out by a number of 
reports (Altenor 6c DeYoe, 1977; Brody, 1969; Ellison & Bresler, 1974) 
that depletion of serotonin by PCPA (|>-chlorophenylalanine) results 
in a state of hyperactivity in the presence of aversive stimulation, 
particularly if shock intensity exceeds 0.5 mA (Tenen, 1967), 
because animals thus treated are unable to suppress irrelevant 
responses to arousing stimuli (Swonger 6c Rech). These findings, 
together with the recent report (Sangdee 6c Franz, 1979) that imipramine 
is somewhat more effective in blocking the reuptake of central 5-HT 
than of NE, suggest that the drug may have attenuated hyperreac­
tivity in response to shock via its action on reducing the reuptake 
of 5-HT at synapses of the raphe"' nuclei, which contain the cell bodies 
for almost all the 5-HT neurons in the brain (Snyder,Shaskan, 6c Kuhar, 
1972), and promoted effective motor action in the presence of shock. 
Since preshock is known to reduce central 5-HT levels (Thierry, 1973; 
Welch 6c Welch, 1970), it is likely that such a transmitter imbalance 
contributed to hyperreactivity in Testing I which was attenuated by 
imipramine. On the other hand, the stabilizing performances of the 
saline animals in Testing II suggest that this phase was character­
ized by conditions producing only moderate or low arousal which were 
controlled adequately by the cholinergic inhibitory system, thereby 
reducing the potential for drug intervention.
Reduction of escape failures. Imipramine significantly
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reduced the tendency of rats to submit to the maximum duration of 
shock (30 sec). This drug effect applied to all groups regardless 
of their experimental histories (cfm. Tables 9 and 10) and also 
included the 3 NS-ES rats which had failed to learn to escape from 
shock in Phase II (see Table 11).
Review of the data (see Tables 4 and 12) shows that ani­
mals treated with imipramine did significantly less wheel turning 
than saline rats (Table 12) while, at the same time, tending to 
escape quicker from shock in Testing I (Table 4) and submitting 
less often to maximum shock treatment (Tables 9 and 10). Most 
studies which tested imipramine!s influence on motor activity exam­
ined motor behavior in the absence of shock or of other forms of 
stressful stimulation (Broitman &  Donoso, 1978; Furgiuele, Aumente, 
&  Horovitz, 1964; Herr, Stewart, & Charest, 1961; Horovitz, 
Furgiuele, High, & Burke, 1964). They reported that for both 
chronic and acute treatments, at doses ranging from 7.5 to 40 
mg/kg, the drug reduced spontaneous motor activity in open fields 
or activity cages. The only study (Porsolt et al., 1978) which 
examined the effects of acute treatment of imipramine on motor 
activity of stressed animals (rats were subjected to an inescap­
able swim prior to drug administration) reported an increase in 
swimming efforts in a subsequent escape task at doses (7.5, 15, 
or 30 mg/kg) which decreased spontaneous locomotion in an open 
field. Such drug x stress interactions have been reported to 
occur also with other drugs (e.g., scopolamine and d-amphetamine) 
and shock (Anisman & Bignami, 1978). Since saline animals in this
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study achieved their relatively high number of wheel turns mostly 
during the intertrial periods during which time the imipramine ani­
mals were observed to remain motionless, it seems likely that imi­
pramine affected escape failures by selectively activating motor 
responses in the presence of shock even though the drug may have 
depressed motor responses in the absence of shock. The selectivity 
of the drug effect suggests again that imipramine may have promoted 
effective motor action by strengthening serotonin-dependent inhibi­
tion of sensory inputs from shock and of maladaptive response tenden 
cies in reaction to shock.
It is, of course, possible that imipramine may have also 
excited motor behavior more directly by preventing the reuptake of 
DA and NE in the brain (Randrup 6c Braestrup, 1977) since both 
transmitters have been reported (Anisman, 1975) to play active 
roles in response initiation and maintenance.
Augmented improvement of performances in Testing I. 
Imipramine's tendency to reduce response latencies across blocks of 
trials in Testing I (see Figure 4) affected all animals treated 
with the drug. Their steeper learning curves in comparison with 
those of saline animals reflect their faster rates of improve­
ment.
However, since this drug effect was manifest only in Testing 
I, the possibility has to be considered that there may have existed 
certain task requirements in this phase of training which worked 
synergistically with imipramine. It may be recalled, for example, 
that each block of trials in Testing I coincided with a different
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shock intensity which ranged from 0.4 mA at block 1 to 1.0 mA at 
block 4. In contrast, shock intensity remained constant at 1.0 
mA in Testing II, and superior improvement of escape latencies 
by imipramine rats was no longer in evidence. Inspection of 
Figure 4 shows that for Testing I, the relationship between shock 
intensities and escape latencies of rats treated with imipramine 
is linear. Latencies continued to decrease sharply (especially between 
blocks 2 and 3) as shock intensity increased. In contrast, latencies 
for preshocked saline rats (but not for saline controls) increased 
slightly as shock intensity was raised above 0.6 mA (block 3).
They were significantly longer than those of imipramine rats at 
block 4 when the shock level was raised for the first time to 1.0 
mA, suggesting differential sensitivity or reactivity to high shock 
intensities, with imipramine animals and saline controls being less 
reactive or sensitive to high levels of shock than preshocked groups 
treated with saline.
As already suggested, imipramine's potential effect on 
increasing central serotonin levels may have attenuated hyper­
reactivity to shock by modulating inhibitory tone in the limbic system 
parallel with high levels of arousal. In view of the report (Tenen,
1967) that serotonin depletion with resulting maladaptive hyper­
reactivity becomes critical when shock intensity exceeds 0.5 mA, the 
better performances at higher shock levels of imipramine animals in 
comparison to those of preshocked saline rats could, therefore, be 
understood by the superior effectiveness of serotonin-dependent 
inhibitory functions mediated by the drug.
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Another explanation for the better performances of imipramine 
animals at higher shock levels involves the possibility of drug-related 
analgesia. Analgesic effects of tricyclics, including imipramine, have 
been observed in man (Beaumont, 1976; Lee & Spencer, 1977), in the 
rabbit (Sigg, 1959); in rats (Houser & Van Hart, 1974; Lapin, 1967;
Lee & Spencer, 1977), and in mice (Lapin, 1967). However, the mechan­
ism of imipramine-induced analgesia is not well understood. Generally, 
it has been suggested (Houser & Van Hart) that the drug may produce 
its pain-relieving effects by acting on the central nervous system to 
reduce the emotional or motivational components of pain. More specifi­
cally, it was proposed (Lee & Spencer) that the emotional reaction to 
pain is controlled by a delicate balance between the NE- and serotonin- 
releasing neurons. That both, serotonin and NE, are important in 
mediating sensitivity to pain has been suggested by a number of studies 
(Lee & Spencer; Lints & Harvey, 1969; Tenen, 1967). For example, it 
was hypothesized that serotonin normally functions to inhibit the 
effects of a painful stimulus (Ladisich, 1974; Lints & Harvey), and 
that sensitivity to pain is probably mediated by NE mechanisms which 
are attenuated by serotonin (Tenen). Such a theory suggests that the 
pain threshold of rats treated with imipramine in this study might have 
been raised by the drug's modification of the balance between NE and 
serotonin in favor of serotonin.
Absence of drug effects on avoidance behavior. Avoidance was 
not significantly affected by imipramine treatment in this study, but 
a tendency of drugged animals to avoid shock less often than their 
saline counterparts was observed (see Figure 7). This potential for
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reducing avoidance responding by imipramine is somewhat surprising in 
view of the possibility that the drug may have facilitated response 
initiation, which is under the control of DA and NE (Anisman, 1975), 
by augmenting the levels of these catecholamines at central synapses.
Actually, the reports on imipramine's effects on avoidance 
are inconclusive. Some studies (Cook & Catania, 1964; Herr et al., 
1961; Kornetsky, 1965; Morpurgo, 1965) concluded that the drug 
impairs avoidance while others (e.g., Crisman, 1967) found that the 
drug does not affect avoidance performance. The data presented by 
Herr, Stewart, and Charest (1961) indicate that the greatest impair­
ments of avoidance were observed to occur approximately 60 to 90 
minutes after injection. Since rats in this study were tested for 
escape and avoidance during a 60-minute interval following injection, 
it is possible that the maximum effect had not yet been obtained 
(especially in the NS-IS group which still showed a high number of 
avoidance responses at the time of testing). Because of the time- 
dependence of the drug effect, variability in testing intervals 
following injection of imipramine may account for some of the incon­
sistent results reported in the literature.
Deterioration of performance between blocks IV and V. Sharp 
increases in escape latencies of all animals treated with imipramine 
occurred between block 4 of Testing I and block 5 of Testing II (see 
Figure 5). The development of this rather pronounced deteriora­
tion in performance coincided with that time in training when shaping 
of wheel turning was stopped, and all animals had to turn off shock 
without any further assistance. In view of the fact that statistical
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analysis had shown that imipramine animals as a group had signifi­
cantly higher latency means at this point (block 5) than saline 
rats, it was thought at first that the effect could be associated 
with a possible depression of motor activity by imipramine treat­
ment since wheel turning without help required more vigorous 
responding. Considering, however, that the performances of the 
NS-NS saline group deteriorated to the same degree as those of the 
imipramine animals (see Figure 5), it seemed unlikely that the effect 
was related directly to any action of imipramine. Rather, the rela­
tively short latencies of drugged rats and saline controls shown in 
Figure 5 for the last three blocks of Testing I suggested that the 
common denominator for this behavior in both groups may have been 
the faster learning of an effective response which was subsequently 
punished by the changing requirements of the task. In support of such 
a hypothesis consider, for example, that by the time assistance in 
the form of controlling the distance of wheel turning was withdrawn, 
all five groups (all groups treated with imipramine and NS-NS saline 
animals) had acquired a well-learned response (minimal push with their 
paws) which suddenly was no longer effective for the termination of 
shock. Rather than being followed by shock offset, as it had been 
in Testing I, this previously successful response was now followed 
by the continuation of shock (punishment). In contrast, it seems 
that the three remaining saline groups, at this point, had not yet 
perceived a contingency between their responses and shock termina­
tion as evidenced by their relatively high latencies at all blocks 
of Testing I (cfm Table 4 and Figure 5), but particularly at block 4.
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It would seem reasonable that without having learned the efficacy of 
a specific response, the preshocked saline rats would not be as 
vulnerable to the momentarily punishing effects engendered by the 
changes in response requirements as were the imipramine animals and 
the saline control group. It is suggested, therefore, that the 
deterioration in performances at block 5 by these fast learners 
may have been the result of response suppression by punishment.
Summary of drug effects on behavior. It was suggested that 
all of imipramine1s influences on behavior were initiated by the 
drug's inhibition of the reuptake of norepinephrine, serotonin, or 
dopamine, an action which has the net effect of increasing the con­
centration of these transmitters at central synapses.
In addition, an attempt was made to relate this direct action 
of imipramine on central transmitter activity to more general pro­
cesses which may have mediated the observed changes in behavior. On 
the basis of recent studies, certain associative (e.g., memory) as 
well as nonassociative processes (motor activity, pain, emotional 
states) were discussed as possible intermediate targets of the 
drug.
In view of the fact that acute treatment of imipramine pro­
duces high levels of central NE which have been associated with 
enhanced memory functioning, it was concluded that improved perform­
ances following preshock could not, as had been proposed in another 
study using chronic treatment schedules, have been mediated by memory 
processes.
The possibility that the drug-induced changes observed in
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Phase III were mediated by enhanced motor activity or improved mood 
were also considered, but the data of this study did not allow a final 
conclusion in favor of either process.
Another interpretation of the drug-related changes revealed 
in the performances of the rats involved the possibility of a drug- 
induced reduction of high levels of arousal which otherwise may have 
interfered with effective motor behavior or strategies in the pre­
sence of shock. In accordance with the gain-setter model (Swonger & 
Rech, 1972), it was hypothesized that one way imipramine may have 
modulated hyperreactivity or arousal in response to shock in all 
animals was by strengthening the serotonin-based inhibitory mechan­
ism of the reticular arousal system through blocking the reuptake of 
serotonin into the serotonergic neurons of the raphe'’ system.
Such a model of drug action is able to account for as seem­
ingly diverse phenomena as the reduction of the preshock effect and 
escape failures, as well as for the selective effects on motor 
behavior (excitation in the presence of shock and depression in 
the absence of shock). The model can also explain the pronounced 
improvement of performances in Phase III of the 3 NS-ES rats which, 
prior to drug treatment, had failed to escape from shock in Phase 
II, and it can account for the accelerated improvement of perform­
ances of drugged rats across trials and increasing shock inten­
sities in Testing I.
An alternative theory for the better performances of imi­
pramine rats at the higher shock intensities considered the drug's 
reputation for alleviating pain. It was proposed that the pain
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threshold of rats treated with imipramine may have been raised by a 
possible modification of the balance between NE and serotonin in 
favor of serotonin. Such an explanation would be consistent with 
the theory that sensitivity to pain is mediated by NE mechanisms 
which, in turn, are attenuated by serotonin.
Behavioral Treatment Effects on 
Physiological Variables 
A number of stress-indicating, physical symptoms had been 
monitored in this study (stomach and intestinal lesions, consumption 
of food and water, as well as changes in adrenal and body weights) 
since it had been suggested (Akiskal & McKinney, 1 9 7 3 ,  1 9 7 5 ;  Leff, 
Roatch, & Bunney, 1 9 7 0 ;  Paykel, Myers, & Dienelt, 1 9 7 0 ;  Thomson 6c 
Hendrie, 1 9 7 2 ;  Winokur, 1 9 7 3 )  that stress plays an important role in 
precipitating depression and that control over stress determines 
not only behavioral but also physiological responses to stress. For 
example, it has been shown (Anisman, 1 9 7 5 ;  Anisman, deCatanzaro, 6c 
Remington, 1 9 7 8 ;  Glazer. Weiss, Pohorecky, 6c Miller, 1 9 7 5 ;  Weiss, 
1 9 7 0 ;  Weiss 6c Glazer, 1 9 7 5 ;  Weiss, Stone, 6c Harrell, 1 9 7 0 ;  Weiss, 
Glazer, Pohorecky, Brick, &  Miller, 1 9 7 5 )  that under conditions 
which allow control over shock, acetylcholine (as well as cortico­
sterone) levels do not go up, and central NE levels do not decline. 
Also, physiological pathologies like gastric ulceration are usually 
absent in those animals who are able to terminate shock.
It had been anticipated that the manipulation of control 
over shock would result in physiological changes which might pro­
vide additional support for a relationship between escapability and
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depression within the framework of the learned helplessness model.
As already stated, the physiological data were generally in 
agreement with the behavioral findings: there were no consistent 
group effects across different physiological factors, but there was 
evidence that preshock was associated with an increase in the inci­
dence of stomach ulcers and that NS-ES rats consumed the least 
amount of food.
Stomach ulceration. The incidence of lesions was monitored 
because the gastrointestinal tract is the most frequently cited 
"target organ" for somatic expression of depressive disorders (Chaplan, 
1 9 7 4 ) .  Furthermore, it is well-documented (Caul, Buchanan, 6c Hays, 
1 9 7 2 ;  Moot, Cebulla, 6c Crabtree, 1 9 7 0 ;  Seligman 6c Maier, 1 9 7 0 ;
Seligman, Maier, & Solomon, 1971; Weiss, 1970, 1971a, 1971c) that 
uncontrollable/unpredictable stress is more apt to induce gastric 
ulceration than an equivalent amount of shock that is controllable.
The incidence of stomach ulcers in this study was relatively 
low. Of 70 animals only 15 (21.4%) developed lesions (see Table 
15). Of the 11 saline rats affected by the lesions, all had been 
exposed to preshock (NS-IS, ES-IS, NS-ES), and none of the saline 
control animals (NS-NS) developed stomach lesions. The majority of 
the ulcers were found in the glandular portion of the stomach (see 
Figures 8 and 9) a site that is associated with an etiology of a 
psychogenic nature in animals and man (Pare 6c Temple, 1973), and 
two were found in the rumen of the stomach (see Figure 10), a 
site which is vulnerable to ulceration as a result of food depriva­
tion (Glavin 6c Mikhail, 1975; Levine 6c Senay, 1970; Moot et al.,
1970; Pare*" and Temple, 1973). The pathogenesis of psychogenic 
stress ulcers has been attributed to an acid rebound effect 
(Desiderato & Testa, 1976; Pare^ 1975). According to this theory, 
the immediate gastric response to shock stress in unrestrained rats 
consists of an abrupt inhibition in volume and acidity of gastric 
secretion, probably as a result of vagal hypoactivity, which in 
the poststress period is followed by hypersecretion due to para­
sympathetic overshoot. Therefore, the greater susceptibility of 
preshocked rats to ulceration in comparison to the control animals 
in this study may simply be the result of quantity rather than of 
quality of shock experience: Preshocked rats were exposed to shock 
twice (three times in the case of ES-IS rats), whereas controls were 
subjected to shock and subsequent acid rebound only once.
Food consumption. The decision to monitor food intake as an 
index of stress had been based on other studies. For example,
Weiss (1968) had found differences in food (and water) consumption 
in his animals, with yoked rats (NS-IS) eating significantly less 
than avoidance (NS-ES) or no-shock (NS-NS) animals. However, since 
NS-ES rats in this study were not singled out on any other parameter 
it is difficult to ascribe their diminished food intake to any behav 
ioral manipulation.
Adrenal weight. Adrenal weight was monitored in this study 
because of reports (Carpenter & Bunney, 1971; Carroll, 1972; Gibbons 
1964, 1966; Sacher, Heilman, Fukushima, & Gallagher, 1970; Sacher, 
Heilman, Roffwarg, Halpern, Fukushima, & Gallagher, 1973) that the 
gross output of glucocorticoids (cortisol and corticosterone) is
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elevated in many depressed patients. Moreover, it has been reported 
(Madden, Rollins, Anderson, Conner, 6c Levine, 1971; Levine, Madden, 
Conner, Moskal, 6c Anderson, 1973; Soderberg, 1967; Vernikos- 
Danellis, 1964; Weiss, Stone, 6c Harrell, 1970; Weiss, Glazer, 
Pohorecky, Brick, 6c Miller, 1975) that inescapable preshock mark­
edly activates the pituitary-adrenal system. The immediate source 
for this activation seems to be the decline of NE levels. For 
example, it has been shown (Ganong, 1974; Ganong, Kramer, Reid, 
Boryczka, 6c Shackelford, 1976; Scapagnini, Annunziato, 6c Preziosi, 
1973, Van Loon, 1976) that there exists a reciprocal relationship 
between NE and ACTH in which hypothalamic NE tonically inhibits 
release of corticotrophin (ACTH) and secretion of corticotrophic 
hormone-releasing factor (CRF). When NE levels decline, the ante­
rior pituitary is disinhibited, resulting in ACTH release and in 
a rise of corticosterone. Even though learned helplessness had not 
been obtained here, it had been hoped that preshock-induced hyper­
secretion of corticosterone would lead to hypertrophy of the adrenal 
cortex, as reflected in an increase of adrenal weight. However, 
there was no evidence of adrenal enlargement in preshocked animals 
(see Table 13).
These findings were surprising because behavioral and phy­
siological preshock effects (stomach ulcers) had been obtained.
Since Selye's discovery (1936) that physiological responses during 
the alarm reaction of the General Adaptation Syndrome (GAS) included 
adrenocortical enlargement, increases in adrenal weight have commonly 
been submitted as evidence of stress. However, it is possible that
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the shock sessions had not been sufficiently chronic in order to 
produce the increase in adrenocortical activity that would also be 
reflected in increased weight of the adrenals. For example, it has 
been stated (Barry & Buckley, 1966) that whereas acute stress is 
associated more with adrenal medullary activation, chronic stress, 
involves primarily the pituitary-adrenal axis.
Body weight. Since other studies (Brodie & Hanson, 1960; 
Friedman & Adler, 1965; Pare'”, 1965; Pare^ & Temple, 1973) have 
reported that stress reduces body weight, changes in weight had 
been monitored from the time of completion of Phase II to autopsy. 
However, no significant changes were noted to occur as a result of 
behavioral treatments.
Other physiological factors. There were no effects on 
water intake or intestinal lesions as a result of behavioral treat­
ment.
Imipramine Effects on Physiological Factors 
Imipramine produced some physiological changes. Animals 
treated with the drug developed fewer stomach ulcers, gained more 
body weight while consuming less food and water than saline rats. 
They also revealed a greater susceptibility to intestinal ulceration 
in comparison to saline animals.
It appears that many of these effects were caused by the 
drug's well-known anticholinergic properties (Beck, 1973; DiMascio 
et al., 1964; Goodman & Gilman, 1977; Sigg, 1959). Animals treated 
with imipramine, for example, had acute constipation which probably 
reduced food intake and had other consequences as well. The
109
discussion which follows will briefly consider the drug's effects on 
each physiological factor and, when possible, will offer speculations 
about mechanisms of drug action.
Stomach ulceration. Rats treated with imipramine developed 
significantly fewer ulcers than saline rats. The effect was partic­
ularly strong for preshocked rats. These results are consistent with 
those cited in other studies (Bonfils, Dubrasquet, Ory-Lavolle, &. 
Lambling, 1 9 6 0 ;  Garattini, Giachetti, Jori, Pieri, 6c Valzelli, 1 9 6 2 )  
which revealed that imipramine provided protection against restraint- 
induced ulcers.
In attempting to delineate the biochemical mechanisms under­
lying the protection against ulceration, it was noted (Brodie 6t 
Hanson, 1 9 6 1 )  that adrenocortical activation impedes the development 
of gastric lesions. However, it is also known (Ganong, 1 9 7 4 ;  Ganong 
et al., 1 9 7 6 ;  Scapagnini e t al., 1 9 7 3 ;  Van Loon, 1 9 7 6 )  that central N E ,  
which in this experiment was probably elevated to a high level by 
imipramine in drugged animals, tonically inhibits ACTH release. It 
is, therefore, unlikely that pathogenesis of stomach ulcers was 
impeded by the drug via adrenocortical mechanisms. Rather, it is 
suggested that imipraminers protection against ulcers was mediated 
by its anticholinergic action which might have reduced vagal hyper­
activity during parasympathetic overshoot in the poststress period.
In support of this hypothesis is the finding (Barry & Buckley,
1966) that anticholinergics can be beneficial in counteracting the 
parasympathetic overstimulation which may cause gastric ulcers.
Intestinal ulceration. In contrast to its protection against
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stomach ulcers, imipramine appears to have mediated the development of 
intestinal ulceration. Of 16 saline rats, only 1 (preshocked) animal 
had an intestinal lesion. However, 9 out of 18 rats examined, which 
had been treated with the drug, developed extensive lesions in 
the intestinal tract. It is suggested that imipramine's contribu­
tion to the pathogenesis of these ulcers was based on its anti­
cholinergic action which produced acute constipation, probably by 
reducing peristalsis. As a result, stomachs were filled like bal­
loons with only partially digested food, and intestines were dis­
tended with pockets of chyme. Ulceration was restricted to sites at 
which chyme had accumulated.
Since intestinal ulcers were found in preshocked imipramine 
rats but not in NPS animals given saline or imipramine, it seems 
that preshock and drug effects interacted to produce lesioned 
intestines.
Body weight. Animals treated with imipramine gained weight, 
whereas saline rats lost weight. Other studies (Broitman & Donoso, 
1978) have reported a decrease in body weight as a result of imi­
pramine treatment in rats and also in rabbits (Stenger, Aeppli, & 
Fratta, 1965). These effects were noted at doses as low as 10 
mg/kg. However, treatment in these cases was chronic and extended 
over a period of 20 days in the first study and 2 weeks in the 
study using rabbits.
It is felt that the increase in body weight observed here may 
be attributed to the partially digested food which was retained in 
the gastrointestinal tract as a result of reduced peristalsis.
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Constipation, which is a well-known side effect of imipramine at the 
beginning of drug treatment (Goodman & Gilman, 1977), may have been 
more severe in this study because of the acute treatment schedule 
used.
Food consumption. Food consumption was monitored since 
anorexia is one of the classic psychosomatic symptoms of depres­
sion (Paykel, 1977), and tricyclic antidepressant drugs are known 
to ameliorate lack of appetite in human subjects (Kupfer, Coble,
& Rubenstein, 1979; Paykel, Mueller, & De La Vergne, 1973). However, 
in this study, animals treated with the drug ate less than saline 
rats, and preshocked imipramine animals ate less than any other 
group. Even though imipramine treatment has been associated with 
reduced food intake and weight loss in rats in another study 
(Broitman & Donoso, 1978), these authors did not propose a mechan­
ism of drug action. However, it seems reasonable to attribute the 
diminished food intake in this study to the effects of constipation.
Water consumption. Water consumption, like food intake, was 
diminished in all animals treated with imipramine. A similar drug 
effect was reported elsewhere (Broitman Sc Donoso, 1978). It is 
suggested that the reduction in drinking was a consequence of 
lowered food consumption and that both factors were secondary to 
cons tipation.
Adrenal weight. There was no evidence of the anticipated 
reduction in adrenal weight as a result of imipramine treatment.
Since secretion of glucocorticoids is under the control of ACTH 
(Turner & Bagnara, 1971), it was expected that the drug might
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diminish adrenocortical activity by increasing the concentration of 
central NE which is known to inhibit ACTH release (Ganong, 1974; 
Ganong et al., 1976; Scapagnini et al., 1973; Van Loon, 1976). 
However, it has been reported (Yuwiler, Geller, Schapiro, &
Slater, 1965) that when imipramine is administered acutely (25 mg 
and 50 mg/kg i.p.) to nonstressed rats, the drug produces sustained 
adrenocortical activation but does not significantly change adrenal 
weight. Their results suggest that adrenal weight is not as sen­
sitive a measure to reflect sustained adrenocortical activation as 
are adrenal and/or serum corticosterone. In addition, the authors 
pointed out that even though the activation in their study was asso­
ciated with a significant elevation of tryptophan and tyrosine 
transaminase, diverse stresses, on the other hand, have been known 
to elicit equally diverse patterns of enzymatic changes. Short of 
direct assay of corticosterone, it seems that the parameters 
(adrenal weight and behavioral measures) used in this study do not 
allow for inferences about the nature and level of adrenocortical 
activity.
Summary of physiological factors. Examination of physiolog­
ical changes in response to manipulation of control over shock showed 
no consistent group effects across different physiological factors, 
but there was evidence that preshock was associated with an increase 
in the incidence of stomach ulcers, attributable to parasympathetic 
overshoot in the poststress period.
Other physiological changes reflected primarily drug-induced 
effects which, for the most part, could be ascribed to the
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anticholinergic action of imipramine. Specifically, it was suggested 
that intestinal ulcers, which occurred primarily in preshocked rats 
treated with imipramine, decreased food and water consumption, and 
increased body weights could be associated with acute constipation, 
probably caused by a reduction of peristalsis in drugged animals. 
Anticholinergic side effects were thought to be particularly severe 
in this study because an acute schedule of drug administration had 
been used.
Imipramine also reduced the susceptibility to stomach ulcers, 
particularly in preshocked rats, and it was suggested that the drug 
produced this effect by diminishing vagal hyperactivity during para­
sympathetic overshoot in the poststress period.
Chapter 5 
Conclusion
This study was designed to determine if a link existed between 
learned helplessness in rats and reactive depression in humans, as 
proposed by Seligman and Maier (1967). In keeping-with the clinical 
treatment paradigm, the antidepressant imipramine was administered 
during a 40-hour period following the "depression-inducing" experi­
ence (uncontrollable shock), and drug effects were tested in a 
subsequent task during which control over shock was possible. It 
had been hypothesized that, in comparison to rats also subjected to 
uncontrollable shock but treated with saline, animals given the 
antidepressant would fail to exhibit the symptoms (e.g., inability 
to profit from successful responses, psychomotor retardation, 
motivational apathy) shared by helplessness and depression. It was 
anticipated that rats would express such symptoms in long escape 
latencies and/or in a high incidence of escape failures.
However, a learned helplessness effect was not obtained in 
this study, and consistent physiological effects (ulceration of the 
stomach as well as reduced food consumption) produced by the behav­
ioral manipulations were limited to preshock (all combined shocks 
of Phases I and II). It was suggested that controllability of 
shock failed to be effective because a number of procedural inno­
vations had been employed which deviated from those used in more 
successful studies,
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Even though helplessness did not occur, imipramine was, never­
theless, able to improve behaviors in Phase III. For example, the 
drug reduced long latencies attributed to the effects of preshock, 
decreased the incidence of escape failures, and promoted faster 
improvement of escape latencies, especially at high shock intensi­
ties .
Since antidepressant effects of imipramine generally develop 
as a result of long-term administration of the drug (Bickel, 1977; 
Oswald, Brezinova, & Dunleavy, 1972), these drug-induced changes of 
behavior were related to some acute effects of the drug which are 
believed (Mandell, 1975) to initiate antidepressant activity after 
prolonged administration. Therefore, associative and nonassociative 
processes were discussed which could have been affected by the acute 
treatment schedule of imipramine. For example, the alleviation of 
the admittedly tenuous preshock effect, which was dependent on the 
data of 6 NS-ES rats which failed to learn to terminate shock in 
Phase II, was compared to similar results obtained with antidepres­
sants in other studies. Inasmuch as the suggestion (Leshner, Remler, 
Biegon, & Samuel, 1979) that treatment with desmethylimipramine 
(DMI) reduced the preshock effect by blocking the memory of inescap­
able shock is attractive, it seems that this explanation may not 
apply here, for it has been shown (Anlezark, 1973; Hall, 1976) that 
decreased memory functioning is related to low levels of central 
norepinephrine (NE). Whereas these may be produced by chronic 
treatment with tricyclics (Schildkraut, 1975), which was employed 
by Leshner, Remler, Biegon, and Samuel (1979), the present study used
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an acute schedule of drug administration which is known to produce 
high levels of NE in the brain (Axelrod et al., 1961). However, 
since high levels of central NE have been associated with enhanced 
memory functioning (Castellano, 1977; Henry, Weingartner, &
Murphy, 1973), it is unlikely that the improved performances of 
preshocked animals in Testing I were mediated by memory pro­
cesses.
Other hypotheses presented to account for the drug-induced 
reduction of the preshock-related behavior impairment considered 
the theory (Anisman, deCatanzaro, 6c Remington, 1978; Glazer, Weiss, 
Pohorecky, 6c Miller, 1975; Weiss, Glazer, 6c Pohorecky, 1976) that 
behavior deficits following preshock are directly related to a 
deficit of motor activation caused by depletion of central NE. 
Imipramine, therefore, could have reduced this impairment by block­
ing the reuptake of NE in the brain. Even though imipramine appeared 
to reduce motor activity in this study, as evidenced by the smaller 
number of wheel turns made by drugged animals, it is, nevertheless, 
possible that this reduction occurred only in the absence of shock 
and that stress and imipramine work synergistically to enhance motor 
activity. Such a theory had, in fact, been proposed to account for 
the reduction of escape failures in Phase III of drugged animals. 
Another hypothesis reported in a recent study (Porsolt et al., 197 8), 
which used acute administration of imipramine, stated that the better 
performances after inescapable trauma of drugged animals were mediated 
by a drug-induced improvement of mood.
While either one of these theories may have some value for
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the decrease in escape failures across Testing I and II, it is felt 
that they, however, cannot account for the fact that a majority of 
drug effects occurred only in Testing I. The preshock effect and 
the greater improvement of performances across blocks of trials 
were confined to this phase of testing in which shock intensity 
had been increased in stages. Furthermore, even though the drug- 
induced reduction of escape failures was evident in both phases of 
testing, the lowest incidence of escape failures (zero) occurred 
at block 4 in Testing I, at which point the maximum shock level 
of 1.0 mA was first introduced.
These results, for example, would be consistent with an 
analgesic effect of imipramine which may have raised the pain 
threshold in drugged animals by changing the balance of NE and sero­
tonin (5-HT) in favor of serotonin, and thereby promoted the better 
performances at the higher shock intensities (in Testing I) before 
adaptation to the highest shock level occurred in Testing II.
However, in addition, the drug-induced changes in behavior which were 
evident in Testing I, as well as the inability of the 6 NS-ES rats to 
learn to turn off shock in Phase II, could also be interpreted by an 
alternative theory. It is possible that an alleviation of high 
levels of arousal in response to shock, which otherwise might have 
interfered with effective motor behavior or strategies in the pre­
sence of shock, was mediated by imipramine. Since imipramine was 
able to produce significant performance changes in the 3 NS-ES rats 
treated with the drug, it was reasoned that these animals suffered 
from an innate impairment of their arousal mechanisms which was
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responsive to modification by imipramine. In accordance with the gain- 
setter model developed by Swonger and Rech (1972), it was hypothe­
sized that one way imipramine may have modulated hyperreactivity or 
arousal in response to shock in all animals was by strengthening the 
serotonin-based Inhibitory mechanism of the reticular arousal system 
through blocking the reuptake of serotonin into the serotonergic 
neurons of the raphe^ sys tem. This theory is particularly attractive 
in view of the fact that imipramine has recently been reported 
(Sangdee & Franz, 1979) of being more effective in blocking the 
reuptake of serotonin than of norepinephrine or dopamine (DA).
The fact that the majority of drug effects occurred in Testing 
I can also be interpreted within the framework of learned helpless­
ness theory if one considers that high levels of arousal are asso­
ciated with anxiety. Seligman, Klein, and Miller (1976), for example, 
have specified the conditions under which anxiety or depression may 
occur. Specifically, they have stated that fear and anxiety develop 
in an organism confronted with traumatic events. If trauma is con­
trollable, anxiety disappears; if control is uncertain, anxiety 
remains. If trauma is uncontrollable, anxiety is eventually displaced 
by depression. It would appear that an argument could be made accord­
ing to which control of shock in Testing I was uncertain, and, there­
fore, produced more arousal, while the animals were still in the 
process of learning the response which terminated shock. Anisman 
(1975) has delineated those factors (endogenous level, turnover, 
synthesis, and degradation of transmitters) which determine the effi­
cacy of a particular pharmacological agent. Accordingly, if the changes
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in endogenous activity induced by stress are severe, then performance 
changes induced by a drug treatment will be different from those seen 
when the changes elicited by stress are relatively small. It is sug­
gested that in addition to preshock effects (enhanced by a deficiency 
in arousal of 6 NS-ES rats) and/or sensitivity to pain, the uncer­
tainty of control typical during any phase of learning may have pro­
duced high levels of arousal which contributed to the changes in 
endogenous activity of the transmitters (5-HT, NE, DA, and possibly 
acetylcholine) amenable to modification by imipramine. In contrast 
to Testing I, Testing II seemed to have lacked the anxiety-producing 
conditions that had prevailed at the beginning of Phase III. Rather 
than providing a variety of shock levels, it was characterized by 
uniform intensity of shock which may have promoted adaptation to pain 
associated with shock. Therefore, rather than representing a period 
of uncertainty characterized by many instances of uncontrollable 
shock, Testing II coincided with a phase in which learning to control 
shock stabilized, and anxiety was diminished by successful coping. 
Consequently, endogenous transmitter activity may have returned to 
normal limits during this phase, reducing the potential for inter­
vention by the drug.
The physiological changes (intestinal ulceration, diminished 
food and water intake, increased body weight) produced by imipramine 
were all identified as side effects of the drug's anticholinergic 
activity. Taken together, the behavioral and physiological results 
preclude an attempt to evaluate the applicability of Seligman's model 
to human depression. In keeping with the clinical treatment paradigm
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and in view of the many drug effects obtained in the absence of 
helplessness, it is suggested that any future attempts to strengthen 
the model via a pharmacological link should be based on chronic 
rather than on acute treatment with antidepressant drugs.
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